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A stra t  
 
This study is conducted to increase the understanding of ovarian follicle development in order 
to enhance and preserve female fertility in mammalian species including experimental 
animals such as mice, production animals such as sheep and is ultimately applicable in 
humans. The primordial follicles, their number and quality determine the longevity and 
quality of female fertility. Regulation of the primordial to the primary follicle transition is 
considered an important factor in preventing depletion of female fertility reserve. Ovarian 
follicle development has mainly thought to be regulated by the action of gonadotropins , 
namely follicle stimulating hormone (FSH) and luteinizing hormone (LH). However, recent 
studies, generated in our laboratory, and that of others, have found that the initial 
recruitment of primordial follicles is in fact, independent of gonadotropin hormones and is 
suggested to be controlled by various intra-ovarian factors, among which are bone 
morphogenetic proteins (BMP).   
It was first thought that BMPs were involved indirectly, through regulating gonadotropin 
production in the pituitary glands. However, some other reports indicate otherwise and 
suggest that ovarian follicle development process is more complicated and regulated by the 
action and interaction between BMP signalling and gonadotropin hormones. However, the 
mechanism of action, interaction and at which level the interactions occur (intracellular or 
extracellular) was not clearly understood. Therefore, with the overall objectives of elucidating 
the role of BMPs, the specific aims of this study were:  
(I) Investigation of the temporal-spatial protein expression of the BMP receptor 1B 
(BMPR-1B), follicle stimulating hormone (FSHR) and luteinising hormone receptor 
(LHR) during 4 stages of follicle development in sheep.  
(II) Study of the role of BMP signalling in the regulation of folliculogenesis including 
the early stage of follicle development, and its influences on primary follicle 
survival rate and ovulation, using mice passively immunised against BMP receptor 
1B (BMPR-IB) and BMP-4 ligand.  
(III) Exploration of the mechanism of interaction between the gonadotropin and BMP 
signalling during follicle development by examining the impact of passive 
immunisation on the protein receptor expression of BMPR-1B, FSHR and LHR, 
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using immunofluorescent localisation combined with 3D image analysis to 
quantify the intensity of the receptors’ protein expression.   
(IV) Investigation of the interaction between BMP signalling and gonadotropins (FSHR 
and LHR) at the transcript level (mRNA). 
As part of the first objective of this thesis and to examine the temporal-spatial protein 
expression of the BMP receptor BMPR-1B, FSHR and LHR during different stages of follicle 
development, the expression of these receptors was analysed in situ and determined 
quantitatively using computerized 3D-image analysis. The result of this study showed that 
BMPR-1B was expressed in the granulosa cells at all stages of follicle development, while FSHR 
was detected in granulosa cells of the primary follicles onward and LHR was absent in both 
primordial and primary follicles granulosa cells but appeared in later stages (secondary 
onward). This study also proved that immunofluorescence labelling combined with intensity 
quantification using computerized 3D-image analysis was an efficient tool for the in situ 
detection and quantification of the small amount of protein in complex tissues such as ovarian 
follicles.  
As part of the second objective, female Swiss mice, aged 21 days, were pass ively immunised 
against BMPR-1B and BMP-4 to examine the role of (BMPs) in the regulation of follicle 
development including the primordial follicles recruitment, primary follicles survival, 
ovulation rate and the interaction with gonadotropin hormones. While a stereological study 
revealed that the number of primordial follicles in immunised mice was significantly higher 
compared to control animals, treatment with eCG showed no effect. In parallel, 
immunofluorescence microscopy examination revealed that the presence of BMPR-IB and the 
lack of FSH receptors in follicle cells of the primordial follicles. Furthermore, estimated 
numbers of primordial and primary follicles in immunised mice were significantly increased 
when compared with control animals. After puberty, the rates of depletion of the primordial  
and primary follicles were increased with age, particularly in treated animals; however, there 
was no significant difference between the treatment groups of the same age. The results of 
this study showed that the passive immunisation against BMP signalling can be used as a 
practical approach in sustaining the reproductive reserve in mammals. In addition, this study 
demonstrated, for the first time, that the BMP signalling is involved directly in regulating the 
ovulation process by increasing the number of corpus lutea. 
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As part of the third objective, the detailed mechanism of interaction between the 
gonadotropin and the BMP signalling system were explored. Female mice were passively 
immunised against BMPR-IB and BMP-4 and also administrated with eCG. This study proved 
that BMPs are not only involved directly in regulating the early stages of follicle development 
but also involved indirectly in regulating the later stages of follicle development by increasing 
gonadotropin receptor expression, which ultimately increase the sensitivity of the follicular 
somatic cell (granulosa and theca cells) toward gonadotropin hormones. 
As a part of the fourth and last objective of the study, the interaction between the BMP 
signalling and gonadotropin hormone receptors expression was investigated at the transcript 
level through quantitative real-time (qPCR). This study was also conducted in mice passively 
immunised against BMP receptor 1B (BMPR-IB) and BMP-4 and also administrated eCG. The 
outcomes of this study showed that attenuation of the BMP signalling significantly increase 
the mRNA expression of the gonadotropin receptor in mice treated with anti-BMPR-1B and 
mice administrated with eCG respectively. Meanwhile, mice treated with anti-BMP-4 showed 
no effects on the gonadotropin receptors expression. This observation, which requires further 
investigation, suggested that the interaction between the BMP signalling and gonadotropin 
hormones occurs at intracellular level (transcript level) and not extracellular level.  
Collectively, all these results generated in this thesis suggest a new strategy for enhancement 
of the reproductive life in mammals through increases in primordial follicle reserve, primary 
follicle survival rate, decreased atresia and increased ovulation rate. Furthermore, the 
outcome of this study showed that BMPs are involved in increasing the follicular somatic cell 
sensitivity toward gonadotropin hormones through increasing the gonadotropin receptors  
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Chapter 1 : The female reproductive system   
1.1 Overview 
In mammals, the male (testis) and female (ovary) gonads of newborns contain a finite number 
of germ cells that serve as a fertility reserve for the whole reproductive age (Ruoss et al., 
2009, Monniaux et al., 2014). In the ovary of young females, germ cells (primary oocytes) are 
incorporated within the primordial follicles; the continuous usage of these follicles results in 
the depletion of the fertility reserve with age, hence causing ovarian function cessation and 
infertility (McGee and Hsueh, 2000). The two gonadotrophic hormones, (FSH) and (LH), 
reported to have a primary role in controlling ovarian function including follicle development 
(Spiteri-Grech et al., 1993, McNeilly et al., 2003, Castilho et al., 2014). The primordial follicles 
recruitment, which was thought to be mainly regulated by gonadotropin hormones, was 
recently shown to be gonadotropin-independent in mice using FSH gene knockout mice 
(Siegel et al., 2013). Therefore, the role of gonadotropic hormones in the regulation of ovarian 
function is now believed to be more complex and influenced by the interactions between the 
gonadotropin and many other intra-ovarian factors, such as BMPs (Shimasaki et al., 2004, 
Wang and Roy, 2009, Shi et al., 2010, Guangqin et al., 2013). BMPs are classified as members 
of transforming growth factor beta (TGF-β  superfa il , that interact by binding to their 
serine/threonine-specific kinase receptors (Rahman et al., 2015) to generate intracellular 
signals by using the intra-cytoplasmic transcription factors SMADs (Pangas, 2012) to regulate 
the basic biological processes and development of the immune system. The present study will 
therefore, focus on the role and significance of BMPs in ovarian function by exploring the 
interaction between BMP signalling and gonadotropin hormones (FSH and LH) using several 
technical approaches in different animal experimental model.  
1.2 Anatomy and Histology of the Ovary 
The ovary is a pair of intra-abdominal organs whose most important function is to release a 
viable and fertilizable egg in a regular cycle (Gougeon, 1996) throughout the process of 
folliculogenesis. Folliculogenesis process ultimately resulting in ovulation, which is a 
continuous dynamic process, with some aspects that take place even during pregnancy 
(Peters et al., 1975), albeit ending at an earlier phase of follicle development. The structure 
of the adult human ovary can be subdivided into three distinct regions (Figure 1-1) (Bloom W 
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and Fawcett D, 1975): the cortex, the medulla and the helium. The cortex comprises the 
surface epithelium, tunica albuginea, ovarian follicle at numerous stages of development and 
the corpus luteum (Bloom W and Fawcett D, 1975). The medulla encompasses large blood 
vessels and nerves (Bloom W and Fawcett D, 1975). The hilum  is the place where the large 
vessels and nerves leave and enter the ovary consisting of large arteries and Leydig cells 
(Bloom W and Fawcett D, 1975). Different studies in the past decade have demonstrated that 
the ovarian function and follicle development to be regulated by several members of the TGF-
β superfa il  such as inhibin, BMPs and activin (Findlay et al., 2002, Wordinger and Clark, 
2007). 
 
Figure 1-1 Representation of the structure of the adult ovary in human 
Sourced from (http://www.pathologyoutlines.com/topic/ovarynontumornormalhistology.html) 
1.2.1 Primordial follicles  
In mammals, the primordial follicles considered as the corner stone in the female 
reproductive system. It comprises in 90-95% of the ovarian follicle (Becker, 2001). 
Histologically, the human primordial follicles (~ 15-25 µm in diameter) contain a small primary 
oocyte surrounded by a single layer of squamous cells and a basal lamina (Saitou et al., 2002) 
(Figure 1-2). Primordial follicles in humans are produced in the fetus during the last trimester 
of pregnancy and hence all oocytes capable of taking part in reproduction already present at 
birth (Kezele and Skinner, 2003). Primordial follicles are regulated by the paracrine/endocrine 
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network of communications between the oocyte, attached granulosa cells, nearby 
theca/interstitial cells as well as surrounding follicles, in addition to the influence of several 
intra-ovarian growth factors such as TGF-β superfa il  (Shimasaki et al., 2004). The first step 
in folliculogenesis is the primordial/primary follicle transition which includes activation and 
growth of a dormant primordial follicle (Fortune, 1994). The first sign of activation of the 
primordial follicle is the changes in its shape from squamous to cuboidal cells morphology. 
The granulosa cells begin to multiply leading to follicle growth and development (Shimizu et 
al., 2004). 
Figure 1-1-2 Diagrammatic representation of a primordial follicle’s structure  
Sourced from: (https://www.studyblue.com/notes/note/n/reproductive-system/deck/2542864) 
1.2.2 Primary follicles 
The primary follicle consists of a cuboidal granulosa cells that are aligned in a single layer to 
surround and enclose the oocyte (Figure 1-3). The expression of  FSH receptor in granulosa 
cells  as well as oocyte growth and development considered  as the main event that takes 
place in the primary follicle development (Williams and Erickson, 2008). The formation of a 
second layer of granulosa cells is exclusive to mammals and termed the primary/secondary 
follicle transition (Dodd, 1977). 
Electron microscope examination of primary follicle oocytes in humans, and compared to 
primordial follicles, reveals an increase in size, in the number of mitochondria and with a 
peripheral cytoplasmic location, the development of Golgi apparatus as several groups of 
smooth vesicles and tubules, and increases in RNA and protein synthesis (James et al., 1976, 




Figure 1-3: Diagrammatic representation of the structure of a Primary follicle  
Sourced from (http://pixgood.com/primordial-follicle.html) 
During the maturation of the oocyte, a small patch of oocyte-derived factors are observed as 
deposits around the oocyte forming a layer of extracellular matrix called the zona pellucida 
(ZP) (Becker, 2001). The human ZP is composed of three glycoproteins: ZP-1, ZP-2 and ZP-3 
(Moos et al., 1995). ZP-3 acts as main sperm receptors and also induce the acrosome reactions 
(Wassarman, 1988). The anti-ZP-3 antibody can block fertilization and hence, has implications 
to be used as a contraceptive vaccine (Levy, 2011, Skinner et al., 1996). Continuous 
development of the primary follicles leads to increases in its size and number of gab junction 
(GJ) between the granulosa cells and the oocyte (Matzuk, 2000). The gap junction is 
comprised of a family of proteins called Connexins (CX) (Becker, 2001). The main function of 
the (GJ), primarily consisting of CX-34 and CX-37, is the maintenance of the cytoplasmic 
communications between neighbouring cells (Gershon et al., 2008). Studies in animal ovarian 
follicle revealed that CX-37 is predominantly present in (GJ) between adjacent granulosa cells, 
while CX-43 is present in (GJ) between granulosa cells and the oocyte  (Kumar and Gilula, 
1996). Studies from CX-37 gene knockout mice revealed that CX-37 is essentials for follicle 
development and fertilization (Simon et al., 1997); however, and while their precise role in 
follicle development is yet to be well determined (Teilmann, 2005).  
1.2.3 Secondary Follicles 
The development of secondary follicles starts when the primary follicles gain  additional layers 
of granulosa cells as the alignment of the granulosa cells changes from a simple cuboidal  to 




Figure 1-4 Diagrammatic representation of secondary follicle 
Sourced from: http://pictures.doccheck.com/com/photo/9949-human-oocyte-secondary-follicle)  
After the primary to secondary follicle transition, 2-8 layers of granulosa cells surround the 
oo te.  A et to e ide tified  sig al that sti ulate the ese h al ells migration toward 
the basal lamina and its division into two primary layers of thecal cells: an inner theca interna 
and an outer theca externa takes place at this stage of development (Erickson et al., 1985, 
Becker, 2001). The theca externa consists of the contractile proteins such as actin and myosin 
(involved in cell movement), whereas the theca interna differentiates into 
glandular/endocrine theca interstitial cells that secrete androgens (Shimasaki et al., 2004). 
The androgen secreted from the theca interna was illustrated to be an obligatory precursor 
for follicle estrogen generation as well as follicle atresia (Erickson et al., 1985). In addition, 
thecal development is associated with the formation of several small blood vessels around 
the developing follicle. The circulating blood transports nutrients and gonadotrophins to the 
developing follicle and removes waste products secreted from the follicle (Williams and 
Erickson, 2008). Another major event during the secondary follicle development is the 
formations of an eosinophilic fluid-filled between the granulosa cells called the Call-Exner 
bodies (Becker, 2001); histological examination reveals that the Call-Exner bodies are made 
up of extracellular matrix which is involved in cell proliferation and differentiation (Meredith 
et al., 1992).  
1.2.4 Graafian follicles 
Similar to the secondary follicle, Graafian follicles also consists of an oocyte, theca cells and 
granulosa cells and is distinguished by the presence of an antrum cavity containing follicle 
fluid adjacent to the oocyte(Williams and Erickson, 2008) (Figure 1-5).  The antrum contains 
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molecules produced from the oocyte and granulosa cells that possess a regulatory effect on 
follicle development (Edwards, 1974). There are two major proteins expressed in follicle fluids 
which were shown to be vital for antrum development: the granulosa-derived kit ligand and 
the CX-37 (Teilmann, 2005, Thomas and Vanderhyden, 2006). The Graafian follicle can 
increase in size by as much as ~75 fold. For instance, in humans, the Graafian follicles can 
increase from ~0.4 mm to ~30 mm in diameter  (McNATTY et al., 1979). The increase in size 
is characterized by granulosa cells proliferation and the accumulation of the follicle fluid 
(Edwards, 1974). The granulosa cells align in specifically shaped and positioned cells, such an 
alignment gives rise to a diverse subtype of granulosa cell structures such as the granulosa 
membrane (mural granulosa), the pre-antral area and the cumulus oophorus (Becker, 2001). 
 
Figure 1-5: Diagrammatic representation of the structure of a Graafian follicle  
Sourced from: (http://biology4isc.weebly.com/1-human-reproduction.html) 
 
1.2.5 The Oocyte 
The ovaries of adult mammals consist of a large number of primordial follicles containing   
primary oocytes arrested in the first meiotic prophase stage of division (Wassarman P and 
Albertini D, 1994) (Figure 1-6). After puberty and upon each estrous cycle, mature oocytes 
resume meiosis and ultimately  undergo ovulation (Wassarman P and Albertini D, 1994). The 
maturation of  an oocyte, as an integrated process of folliculogenesis,  is regulated by several  
factors, predominantly the pituitary gonadotrophin hormones  (Wassarman P and Albertini 
D, 1994). The meiotic maturation of an oocyte entails the transformation of immature of an 
oocyte to a fully grown oocyte presents in the pre-ovulary follicles ready for fertilization  just 
before ovulation (Wassarman P and Albertini D, 1994). This process is regulated by the 
interaction of pituitary gonadotrophins with a variety of autocrine and paracrine factors of 




Figure 1-6: Structural diagram represents human’s oocyte  
Sourced from : (http://pictures.doccheck.com/com/photo/9949/size/m) 
1.2.6 Granulosa cell 
Granulosa Cells stem from the mesonephric cells throughout embryogenesis, where their 
number multiplies with follicle growth and affected by levels of estrogen and several intra-
ovarian growth factors (Erickson and Danforth, 1995). During folliculogenesis, granulosa cells 
are unable to produce estrogen until theca cells transform into androgen producing cells. In 
gra ulosa ells, the e z e 7β-hydroxysteroid dehydrogenase converts the substrate 
androstenedione into testosterone, and the enzyme P450-aromatase converts the 
testosterone produced into estradiol. Figure 1-7 presents a detailed schematic presentation 




Figure 1-7: Estradiol production in granulosa cells 
 Sourced from: (https://www.researchgate.net/figure/261140191_fig1_Two-cell-theory-of-estrogen-production-Luteinizing-hormone-
stimulates-the-production-of) 
Before the mid-cycle gonadotrophin surge that takes place on day-14 of the menstrual cycle, 
granulosa cells predominantly secrete estradiol. Afterwards, granulosa cells shift to produce 
progestin (Erickson and Danforth, 1995). Both FSH and LH augment the production of 
progesterone from granulosa cells by enhancing the uptake of lipoproteins, freeing 
cholesterol from lipoproteins, transforming cholesterol into pre-gnenolone and then 
subsequently converting pre-gnenolone into progesterone (Hsueh et al., 1984).     
1.2.7 Theca cell 
During the secondary stages of follicle development, stromal cells align side by side near the 
basal lamina to form the theca layer (surrounds granulosa cells) (Gougeon, 1986) ultimately 
forming an outer and inner sections of theca layer  (Gougeon, 1986). The outer section, called 
the theca externa, comprises undifferentiated theca cells and the inner section, called the 
theca interna, having similar appearance with the steroid secreting cells (Figure 1-8) 
(Gougeon, 1986). In bovine ovaries, BMP-4 was shown to be situated in the theca interna as 
well as in the oocyte (Fatehi et al., 2005). The existence of BMP-4 and BMP-7 in thecal cells 
indicates that these proteins play a role in follicle steroidogenesis since estradiol production 




Figure 1-8: Histological presentation of theca cells in a Graafian follicle  
Sourced from: http://mesa-anatomy.weebly.com/reproductive1.html 
1.3 Follicle development and function (Folliculogenesis)  
In humans, folliculogenesis comprises a chronological series of events where growing follicles 
either mature to ovulation or die by apoptosis (Filicori, 1999, Scaramuzzi et al., 2011, Hsueh 
et al., 2015). The process of folliculogenesis is a relatively long, and takes approximately one 
year for a primordial follicle to develop through to the ovulatory stage (Gougeon, 1996, 
Williams and Erickson, 2008). The early stages comprise the primordial follicle transition, the 
differentiation and development of follicular somatic cells (granulosa and theca), dominant 
follicle selection, ovulation, followed by corpus luteum formation and/or atresia (Roche, 
1996, Shimasaki, 2006, Shimizu et al., 2004, Hutt and Albertini, 2007, Field et al., 2014). The 
recruitment of primordial follicle to the pool of growing follicles is considered to be a key 
limiting step in folliculogenesis process (Fortune et al., 2000). Folliculogenesis takes place in 
two phases: the first phase is the pre-antral phase which requires around 290 days – includes 
the characteristic development of the oocyte and the development of a recruited primordial 
follicle into a primary follicle (Gougeon, 1996, Williams and Erickson, 2008). The second phase 
is the antral phase that requires around 60 days, where antrum formation is initiated followed 
by all the developmental changes up to the Graafian follicle stage.  Generally, one or two 
dominant follicles are selected from a large antral group after which it takes around 20 days 




Figure 1-9: Schematic representation of folliculogenesis process in humans  
Sourced  from: (Williams and Erickson, 2008)  
1.4 Gonadotropin hormones and Hypothalamus pituitary-gonadal axis 
The pituitary gland synthesises and releases of the two gonadotropin hormones, FSH and LH 
which considered as the main players controlling the functions of the gonads (ovary and 
testis). Gonadotropins production and release is regulated by a tightly coordinated system, 
which called hypothalamic-gonadal-pituitary (hypothalamic, pituitary and gonadal axis) 
(Figure 1-10) (Faure et al., 2005). The release of the hypothalamic gonadotropin-releasing 
hormone (GnRH) from the hypothalamus, in pulses manner, appeared to be the primary 
stimulus for FSH and LH production and release from the pituitary gland (Faure et al., 2005). 
The frequency of GnRH pulses exhibits selective effect on FSH and LH secretion, where a high 
frequency of GnRH pulses stimulates LH secretion and a low frequency of GnRH pulses 
stimulates FSH secretion (Molter-Gerard et al., 1999). Other factors such as gonadal steroids, 
progesterone and estradiol also regulate FSH and LH release. FSH plays vital roles in several 
gonadal functions such as follicle development, proliferation of granulosa cells, LH production 
and steroid production (Fauser and Van Heusden, 1997). In addition to the influence of GnRH, 
it is well established that FSH secretion is also regulated by members of the TGF-β superfa il  




Figure 1-10: The hypothalamic-pituitary-gonadal axis  
Sourced from: (Kong et al., 2014)  
1.4.1 FSH Action in the Granulosa Cells 
The human functional FSH-Receptor protein consists of 678 amino acids with three domains: 
a) a large extracellular amino-terminal ligand binding domain b) the heptahelical 
transmembrane spanning domain c) and the intracellular carboxyl-terminal domain (Findlay 
et al., 2002). The primary mechanism by which dominant follicle selection and development 
take place is through FSH-Receptor pathway activation in the granulosa cells (McGee and 
Hsueh, 2000, Williams and Erickson, 2008). The FSH signalling pathway is commencing with 
binding of FSH to its receptor, leading to a conformational change in the transmembrane 
domain of the receptor (Findlay et al., 2002, Guangqin et al., 2013). Such an alteration leads 
to the activation of the heterotrimeric G protein (Gs), through an exchange of (GTP) for (GDP). 
The active (Gs-GTP) subunit activates adenylate cyclase which produces the second massager 
cAMP. Consequently, cAMP interacts with protein kinase A (PKA) generating two free catalytic 
subunits. FSH modulation via the cAMP/PKA pathway in the granulosa cells accounts for 
dominant follicle growth as well as development to the pre-ovulatory stage (Williams and 
Erickson, 2008). As illustrated in (Figures 1-11). This is not the only signalling pathway 
activated by FSH; it has also been shown to activate the cAMP/PKA pathway (Hunzicker-Dunn 
et al., 2012). Furthermore, FSH was also illustrated to act via the P13K pathway, Src family of 
tyrosine kinases, G-protein RAS, extracellular related kinases (ERK 1/2) and P38 mitogen-
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activated protein kinase (Hunzicker-Dunn and Maizels, 2006). Thus FSH signals through the 
P13K pathway was suggested to bring the activation of pro-survival factors in granulosa cells 
(Williams and Erickson, 2008).  
FSH is considered the key stimulator of granulosa cell activities  in the ovary (Gougeon and 
Testart, 1990). Additionally, various growth factors produced have a significant influence on 
granulosa cell proliferation (Williams and Erickson, 2008). For example, oocyte-derived GDF-
9 and BMP-15 play a role in granulosa cell activation via modulation of FSH signals (Otsuka et 
al., 2011). FSH may act synergistically with such growth factors to activate human granulosa 
cell proliferation (Williams and Erickson, 2008). 
 
 
Figure 1-11: Illustration of the FSH Signal Transduction Pathway in the granulosa cells  





1.4.2 LH Action in Theca Interstitial Cells 
LH-Receptor in human consists of 675 amino acids (Filicori, 1999). Similar to the FSH, LH 
consists of three domains: a) an extracellular leucine-rich ligand binding domain b) a 
heptahelical transmembrane domain c) and the intracellular domain for G protein 
interactions (Filicori, 1999, Williams and Erickson, 2008). However, a number of truncated 
forms (which determine the biological activities  of LH)  of the LH receptor not containing the 
transmembrane domain have also been described (Williams and Erickson, 2008). One of the 
events that are required for the further development of the pre-ovulatory follicle is the 
expression of the granulosa cells LH-receptor (McNeilly et al., 2003). The LH receptors remain 
repressed until late in the follicle cycle and FSH plays an important role in LH-Receptor 
induction (McGee and Hsueh, 2000, Meldi et al., 2012). Oocyte-derived inhibitors are  
responsible for blocking the FSH-induced the expression of LH receptors in granulosa cells 
until the onset of the pre-ovulatory stage (McGee and Hsueh, 2000). Once expressed, LH binds 
to the LH-Receptor with a high affinity leading to the conformational change in the receptor 
and activation the G proteins (Filicori, 1999).  
 
Figure 1-12: Regulatory mechanisms of estrogen production by theca interstitial cells 
 Sourced from: (http://www.sciencedirect.com/science/article/pii/S13572725050005) 
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LH receptor activation is similar to FSH receptor activation in that it leads to downstream 
activation of the Gs/adenylate cyclase/cAMP and PKA pathway (Williams and Erickson, 2008). 
It was demonstrated that other G proteins (Gi and Gq) may be activated upon LH receptor 
stimulation to mediate LH-induced activation of phospholipase C and its signalling pathways 
(Ascoli et al., 2002). Ultimately, stimulation of the LH receptor activates LH signalling 
pathways that lead to the synthesis of androstenedione (Williams and Erickson, 2008). Figure 
(1-12) presents an illustration of LH induced activation of the LH receptors and the 
downstream LH signalling pathways. 
1.5 Ovulation and atresia 
The human ovaries normally produce a single dominant follicle from growing and developing 
follicles in each menstrual cycle (McGee and Hsueh, 2000), and this follicle is responsible for 
enhanced estradiol secretion that occur during the late stages of follicle development, and 
maturation of the dominant follicle (Williams and Erickson, 2008). After ovulation, the 
remaining of the dominant follicle develops into the corpus luteum (under influence of LH) 
and produces large quantities of progesterone throughout the luteal phase of the menstrual 
cycle (Williams and Erickson, 2008). The estradiol and progesterone generated act 
synergistically to prepare the uterus for the embryonic implantation (Bazer, 2013). However, 
continuous follicular atresia and ovulation lead to the complete depletion of ovarian follicles 
reserve, which ultimately results in ovarian failure and the cessation of menstrual cycle in 
women. Thus the menopausal state (Ruoss et al., 2009).  
Very few of mammalian follicles develop to maturity, with 99.9% of follicles dying due to 
atresia, the onset of the latter occurring through activation of apoptotic activity in the oocyte 
and granulosa cells (Ksiazkiewicz, 2006). Apoptosis may be initiated by extracellularly derived 
ligand/factors (apoptotic factors su h as tu or e rosis fa tor TNFα form epithelia/stromal 
cells) binding to the granulosa cells or the oocyte surface. Also, apoptosis can be initiated 
intracellularly by ha gi g the ito ho dria’s outer e ra e per ea ilit  to se rete the 
pro-apoptotic factors into the cytoplasm (Williams and Erickson, 2008, Matsuda et al., 2012). 
FSH is considered to be a survival factor for Graafian follicles due to its sustained role in follicle 




Chapter 2 : The Transforming Growth Factor (TGF-Β) Superfamily 
The TGF-β superfa il , up to date, comprises of 42 members and can be further subdivided 
into subfamilies, such as the nodal family, myostatin TGF-β fa il , the i hi i  fa il , the 
activin family, Mullerian Inhibiting Substance (MIS) and BMPs (Campbell et al., 2012, Rossi et 
al., 2015). TGF-β superfa il  ha e a unique structural feature where the existence of nine 
conserved cysteine residues, eight of which are involved in forming the characteristic cysteine 
knot structure of the molecule in the three-dimensional form (Vitt et al., 2001). The ninth 
conserved cysteine residue is engaged in formation of a di-sulphide bridge between the two 
subunits, which is responsible for the formation of a covalently linked and biologically active 
dimer (Jones et al., 1994). All members of TGF- β superfa il  i ludi g that in human, rat, sea 
urchin, mouse, worm, cattle, zebrafish and chicken have conserved residues, such as valine 
or leucine or isoleucine at the 31st amino acid. Hence, its substitution with an acidic amino 
acid causes a critical change in its function (Shimasaki et al., 2004).  
2.1 TGF-β Re eptors 
The TGF-β superfa il  sig als through a tra s-membrane cellular receptor, which binds to 
specific ligands, such as hormone growth factors and neurotransmitters (Attisano and Wrana, 
2013). The ligand binding causes activation of various intracellular pathways that promotes a 
particular gene expression which ultimately regulates a specific biological response 
(Chedrese, 2009). Almost all members of the TGF-β superfamily belong to serine/threonine 
kinase class of receptors (Massague, 1998). The serine/threonine kinase receptors are of two 
types: type I and type II receptors (Derynck and Zhang, 2003). type I exists in seven forms such 
as Activin Receptor-Like Kinase, ALKs 1-7, whereas type II exists in five forms, such as TβR-II, 
ActR-II, ActR-IIB, BMPR-II and AMHR-II (Derynck and Zhang, 2003). 
2.1.1 Structure of TGF-β Receptors  
The structure of the TGF-β re eptor o tai s three fu tio al do ai s: a  e tra ellular 
domain, (b) GS domain (transmembrane bounds), and (c) Kinase domain (intra-cytoplasmic) 
(Massague, 1998). The extracellular domain consists of about 150 amino acids and is 
concerned with modulating TGF-β respo ses (Lin and Wang, 1992). The GS domain is highly 
conserved among the type I receptors and consists of 30 amino acids that precede the kinase 
domain (Lin and Wang, 1992). The GS domain is essential for type I receptor signalling due to 
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the presence of the phosphorylation site, which is required for the signal transduction. The 
phosphorylation site in the GS domain is phosphorylated by the type II receptor, which when 
mutated may prevent the phosphorylation of type I receptor (Attisano and Wrana, 2002). The 
kinase domain plays a key role in the phosphorylation of Smad proteins (discussed further 
below) in both type I and type II receptors, thus indicating the importance of the kinase 
domain in downstream receptor signalling (Figure 2-1) (Massague, 1998). 
 
Figure 2-1: Smad-dependent TGF-β signalling pathway 
 Sourced from: (http://www.motifolio.com/) 
Members of the TGF-β t pe I re eptor fa il , ha e high si ilarit  ith their ki ase do ai s  
and signalling properties and are further divided into three groups: (a) ALK-5, ALK-4and ALK-
7; (b) ALK-3 and ALK-6 and (c) ALK-1 and ALK-2 (Chang et al., 2002). TGF-β t pe II re eptor 
fa il  o prises of three e ers: a  TβR-II, (b) BMPR-II and (c) AMHR-II (Chang et al., 
2002). Table 2-1 summarizes the members of TGF-β seri e/threo i e ki ase re eptor family. 
The ligand-receptor binding relationships between several BMP ligands and their respective 
receptors are not restricted (Shimasaki et al., 2004). ActR-II and ActR-IIB initially discovered 
as activin receptors were it also act found to act as receptor of BMP-6 (Ebisawa et al., 1999), 
BMP-7 (Yamashita et al., 1995) and GDF-5 (Nishitoh et al., 1996). By contrast, BMPR-II 
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receptors bind specifically to BMP ligands, including BMP-2 (Liu et al., 1995), BMP-4 (Nohno 
et al., 1995), BMP-6 (Ebisawa et al., 1999), BMP-7 (Rosenzweig et al., 1995), BMP-15 (Moore 
et al., 2003) and GDF-9 (Vitt et al., 2002).  
Table 2-1: The relationships between ligands, receptors and Smads of the TGF-β superfamily 
Sourced from: (Shimasaki et al., 2004) 
 
In terms of TGF-β superfa il  t pe I re eptors, ALK-2 (ActR-IA) (Macias-Silva et al., 1998), ALK-
3 (BMPR-IA) (Gilboa et al., 2000) and ALK-6 (BMPR-IB) (Aoki et al., 2001) have been illustrated 
to be similar to BMP type I receptors, where overexpression of these BMP type I receptors  
activates BMP-specific signalling pathways (Fujii et al., 1999). BMPR-ligand interactions are 
complex, in that there is much cross-reactivity among various BMP ligands with BMP type I 
receptors (Shimasaki et al., 2004). To add to this complexity is the specific binding of BMP 
ligand to different BMP type I receptors in different types of cells (Shimasaki et al., 2004). For 
instance, in C2C12 and MC3T3-E1 cells, BMP-6 binds to ActR-IA and BMPR-IA, but with higher 
affinity to ActR-IA (Ebisawa et al., 1999). In ROB-C26 cells, BMP-6 binds to ActR-IA, BMPR-IA 
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and BMPR-IB, but with a higher affinity to BMPR-IB in comparison to ActR-IA and BMPR-IA 
(Ebisawa et al., 1999). Despite the complexity in the BMPR-ligand interactions, numerous  
research studies have identified a preferential of certain BMP ligands to bind to BMP type І 
receptors. For instance, BMP-2, BMP-4 and GDF-5 have a preference to bind to BMPR-IA and 
BMPR-IB (Aoki et al., 2001). Moreover, BMP-6 and BMP-7 preferentially bind to ActR-IA and 
BMPR-IB (Aoki et al., 2001). In addition, BMP-15 most readily binds to BMPR-IB and BMPR-IA, 
with a higher affinity to BMPR-IB (Moore et al., 2003). GDF-9 has been identified to bind to 
BMPR-II receptor (Vitt et al., 2002).  
2.2 The BMPs 
The term BMP, first described in 1965 by Urist (Urist M., 1965), was used to describe bone  
components capable of stimulating bone and cartilage formation and repair (Shimasaki et al., 
2004). In addition to mitogen stimulating activity, BMPs can also function uniquely as a 
morphogen in transforming connective tissue cells into osteoprogenitor cells (Rengachary, 
2002, Yanagita, 2009). BMP liga ds e ist i  the ell’s cytoplasm as dimeric inactive pro-
proteins containing a signal peptide, pro-peptide and mature portion. Proteolytic cleavage of 
the pro-peptide leads to the releases of mature peptide which forms homo or hetero dimers. 
BMP heterodimers have greater biological activity than their respective homodimers (Suzuki 
et al., 1997). Signal transduction by the BMP ligand requires heterodimers complex containing 
Type-I and Type-II trans-membrane serine-threonine kinase receptors (Liu et al., 1995). 
Mature BMPs are released into the extra-cellular compartment, where they bind to specific 
BMP cell membrane receptors (Degnin et al., 2004). BMPs are engaged in multiple cellular 
activities such as proliferation, cellular differentiation, migration, organization and apoptosis 




2.4.1 Members of BMP family 
The BMPs comprise of 20 members, of which seven were discovered originally. They are 
further subdivided into three categories according to their sequence identities. The first 
category contains BMP-2 and 4, the second category contains BMP-5, BMP-6 and BMP-7 (also 
known as osteogenic protein-1) while BMP-3 (also known as osteogenin) stands alone in the 
third category. Six of the seven BMPs, which were originally discovered (BMP 2-7), belong to 
TGF-β superfa il  hile BMP-1 is a metalloprotease protein. Knockout analysis of one or 
more members of BMP family indicated redundant functions; however, each of them 
regulates specific functions which are summarized in (Table 2-2).  
Table 2-2: Functional analysis of BMP genes 






Though BMP-1 was initially classified as member of BMPs family due to its stimulatory 
properties in bone and cartilage development, it was later discovered to also function as a 
metalloproteases with similarity to pro-collagen C proteinase (PCP) (Kessler et al., 1996). 
BMP-1 neither shares any structural similarity to other BMPs nor any growth factors; 
therefore, it is not categorized as a member of the TGF-β superfa il  (Shimasaki et al., 2004, 
Wozney et al., 1988). It is, rather, required to cleave the C-terminus pro-peptides of 
procollagen I, II and III during cartilage and bone development. BMP-1 is also involved in skin 
development in several species (Amano et al., 2000).  
A study using  immunohistochemistry technique has revealed that BMP-1 is expressed in the 
oocyte and the granulosa cells of all stages of follicle development in sheep suggesting that 
BMP-1 is involved in the follicle development (Canty-Laird et al., 2010), but the mechanisms 
is poorly understood.  
2.4.2 BMP-2 (BMP-2A or BMP-2α) 
BMP-2 has been shown to be involved in diverse cellular physiological functions including 
development of cartilage (Wozney et al., 1988), bone (Tabas et al., 1991), differentiation of 
cardiac cell, transition from epithelial to mesenchymal type and signalling  pathways, such as 
the hedgehog path a , TGF β path a  a d toki e-cytokine interactions. BMP-2 appears to 
be critical for the embryological development, non-small cell lung carcinoma and tumor 
growth and osteoblast differentiation (Langenfeld et al., 2003). For instance, BMP-2 deficient 
mice were found to be incapable of surviving during embryogenesis (Zhang and Bradley, 
1996). Finally, BMP-2 has been shown to augment FSH-induced estradiol production, FSHR 
expression in granulosa cells as well as Inhibin (A) production (Guangqin et al., 2013, Souza et 
al., 2002). 
2.4.3 BMP-4 (BMP-2B or BMP-2β) 
BMP-4 is a highly conserved regulatory protein of TGF-β superfa il , hi h pla s a ital role 
in the central and peripheral nervous system as well as in the development of the muscular 
and skeletal systems (Sedohara et al., 2002), specifically bones from mesoderm, cartilages, 
tooth and limb repair after fracture. BMP-4 along with fibroblast growth factor FGF2 
stimulates stem cell differentiation to mesodermal lineages. Mice that have had the BMP-4 
gene deleted, formed little or no mesoderm and died during gastrulation (Winnier et al., 
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1995). In addition, BMP-4 heterozygous mice exhibited a range of birth defects such as a 
decreased number of primordial germ cells (PGC), polydactyl, abnormal kidney, eye and 
craniofacial development (Chang et al., 2002). In the Human ovarian theca-tumor (HOTT) cell 
culture model showed that BMP-4 treatment resulted in the reduction of forskolin-enhanced 
HOTT cells secretion of androstenedione, 17-α-hydroxyprogestrone and augmented 
production of progesterone (Dooley et al., 2000). BMP-4 is primarily expressed in theca cells 
of rat ovaries (Shimasaki et al., 2004). BMP-4 plays a bio-vital role in the reduction of FSH-
induced production of progesterone and enhanced FSH-induced estradiol generation in rat 
granulosa cell cultures (Shimasaki et al., 2004). Furthermore, research in ewe pituitary by 
Faure et al. showed that BMP-4 reduced the secretion of FSH by stimulating the 
phosphorylation of Smad-1 (Faure et al., 2005). Thus, the effect of BMP-4 on FSH secretion 
was suggested to be due to the activation of BMP signalling pathways (Faure et al., 2005).  
2.4.4 BMP-5 
BMP-5 expression is associated with limb and bone, cartilage development, dendritic growth 
in the sympathetic nervous system as well as in cell death (Zuzarte-Luis et al., 2004). Its 
expression was observed in the trabecular meshwork, optic nerve head, lung and liver. BMP-
5 does not show strong osteogenic potential in pre-osteoblast cell lines (Cheng et al., 2003). 
Several loss of function mutations showing short ear phenotypes and localized skeletal 
defects in mice have been assigned to BMP-5 gene function (Kingsley et al., 1992). Moreover, 
the expression of BMP-5 shown to associated with granulosa cell proliferation and steroid 
production in rat ovary (Faure et al., 2005).  
2.4.5 BMP-6 (VGR-1) 
BMP-6 was identified due to the ability of the demineralized bone extracts to induce 
endochondral osteogenesis in an extra-skeletal site. It plays a vital role in cartilage and bone 
development and known for inducing the osteogenic markers in mesenchymal stem cells 
(Yang et al., 2003). BMP-6, does share redundant functions with other BMP members, namely 
BMP 5 and 7. Single knockouts containing BMP-7 are either embryonic lethal to embryos or 
have severe phenotypic effects but unlike the double knockout (e.g of 5 and 6), single 
knockout of BMP-5 and 6 genes do not show gross abnormalities (Solloway and Robertson, 
1999). The expression property of BMP-6 is more akin to BMP-2 in hypertrophic cartilage, 
suggesting that BMP-2 may be compensating for the functions of BMP-6 in homozygous mice 
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mutants (Solloway and Robertson, 1999). BMP-6 treatment of L-β-T2 cell cultures in mice was 
associated with an increased production of endogenous FSH (Huang et al., 2001) by inhibiting 
adenylate cyclase (and therefore cAMP generation). This effect was seen in both responses 
to FSH action and to the adenylate cyclase activator Forskolin (Shimasaki et al., 2004). In 
context of ovarian function, BMP-6 has been demonstrated to inhibit some of the effects of 
FSH on gene expression, for example reducing the expression of FSH stimulated LH-receptor 
mRNA expression in follicle cells (Shimasaki et al., 2004). BMP-6 was also shown to be 
effective in blocking FSH-induced progesterone production, but interestingly not FSH-induced 
estradiol production (Shimasaki et al., 2004). During rat follicle development, BMP-6 mRNA 
expression was drastically reduced at the time of dominant follicle selection. Hence, it is 
suggested that the mechanism of dominant follicle selection prior to ovulation could be 
driven by downregulation of BMP-6 thus enhancing the FSH effect (Shimasaki et al., 2004). 
2.4.6 BMP-7 (OP-1) 
BMP-7 was initially purified as an osteogenic protein with a role in bone development, kidney, 
eye functions and reproduction (Lee et al., 2004). It has been shown that BMP-7 is co-
expressed with BMP-5 in several tissues (Solloway and Robertson, 1999). Compound BMP-5 
and BMP-7 mutant mice show cardiac (e.g. defective chamber septation) and other 
developmental abnormalities that are ultimately lethal. This indicates the function of BMP-5 
in mutant mice was functionally compensated by BMP-7 which reflected the redundant 
nature of BMP-5 and BMP-7 previously mentioned (Solloway and Robertson, 1999). BMP-7 
was shown to amplify FSH induced expression of P450 aromatase while blocking the mRNA 
expression of steroidogenic acute regulatory protein (StAR) (Lee et al., 2004). The study 
conducted by Lee W. et al. showed that BMP-7 modulates FSH-dependent estradiol and 
progesterone production by the expression of P450 arom and StAR (Lee et al., 2001b). BMP-
7 was shown to reduce the number of primordial follicles, yet increase the number of primary, 
secondary as well as antral follicles, thus could enhance the recruitment of primordial follicles 
to the growing follicle pool (Shimasaki et al., 2004). 
2.4.7 BMP-15 (GDF-9B) 
BMP-15, an oocyte derived growth factor, also known as GDF-9B due to its high homology to 
GDF-9 and the co-expression with GDF-9 in oocytes (Yang et al., 2003). BMP-15 expression in 
oocytes is initiated during the recruitment of primordial follicles to primary follicles, and 
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expression continues until ovulation (Dube et al., 1998). Several mouse model analyses 
indicated that BMP-15 and GDF-9 play major role in late staged of folliculogenesis and 
following ovulation, however the functions of these two follow diverse paths in mono and 
poly-ovulatory mammals (Galloway et al., 2002). Genetic analysis studies have illustrated that 
heterozygous mutations in BMP-15 expression has resulted in the exhibition of hyper-
gonadotropic ovarian failure, an under-developed uterus, primary amenorrhea and hirsutism 
(Di Pasquale et al., 2004). BMP-15 mitotic activity takes place independently from FSH, it can 
induces granulosa cell mitosis in pre-antral follicles, during the early stages of follicle growth 
(Shimasaki et al., 2004). similar to BMP-6, BMP-15, inhibits FSH-stimulated progesterone 
production without affecting the estradiol production in rat granulosa cells (Shimasaki et al., 
2004). Other FSH induced actions such as LH receptor  inhibin/activin expression and 
steroidogenesis are also blocked by BMP-15 (Shimasaki et al., 2004).  
Follistatin, an activin binding protein, has been shown to play a crucial role in regulating 
folliculogenesis by binding to BMP-15, and inhibiting BMP-15 stimulation of granulosa cell 
proliferation, FSH receptor expression as well as progesterone generation (Otsuka et al., 
2011, Shimasaki, 2006). Follistatin has been shown to be highly expressed in dominant 
follicles and minimally or untraceable in atretic follicles in rat ovaries.  
2.4.8 GDF-5 
GDF-5 is a member of the TGF-β superfa il  that is i pli ated i  se eral skeletal 
developmental processes including chondrogenesis and joint formation. Mutations in the 
GDF-5 gene resulted in chondrodysplasias such as Hunter-Thompson and Brachydactyly 
(Nickel et al., 2005). GDF-5 exhibited a higher binding specificity to the type I receptor, 
exclusively binding with BMPR-IB (Mueller and Nickel, 2012). Deletion of either GDF-5 or 
BMPR-IB in mice exhibited a similar phenotype in both groups of mice, suggesting that GDF-
5 signalling  is greatly dependent upon the binding to BMPR-IB (Nickel et al., 2005). Human 
GDF-5 showed modulatory activity in regeneration of collagenous soft connective tissue and 
ligament (Jenner et al., 2007). Loss-of –function of GDF-5 [brachypodism] showed its 
importance for normal function specific set of skeletal elements (Storm et al., 1994). 
Structural as well as mutational analyses identified a single residue (Arg57) in the pre-helix 
loop of GDF-5 which is critical for high affinity and binding specificity to the BMPR-IB. variant 
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GDF-5 (GDF-5R57A) is capable of binding to both BMPR-IA and BMPR-IB with a higher affinity 
compared to the non-variant GDF-5 (Nickel et al., 2005). 
2.4.9 GDF-9 
GDF-9, a derivative of oocyte growth factor, controls numerous steps in folliculogenesis, 
including differentiation of all follicle compartments such as oocyte, follicle granulosa and 
thecal cells (Vitt et al., 2000). Whereas, GDF-9 was shown to be not required for male fertility, 
homozygous GDF-9 females were infertile. Adding GDF-9 to cultured human ovarian tissue 
promotes the early stages of folliculogenesis (Hreinsson et al., 2002). The growth and 
progression of the oocyte in GDF-9 deficient ovaries is abnormal showing a) faster 
development than control oocytes b) peri-nuclear organelle aggregation and abnormal 
peripheral Golgi complexes c) failure to develop cortical granules (Shimasaki et al., 2004). 
GDF-9 was shown to induce granulosa cell mitosis, where it increased granulosa cell 
proliferation and DNA production (Vitt et al., 2000). GDF-9 knockout mice ovaries lacks the 
ability to recruit theca cell precursors, thereby lacking the expression of mRNA that codes for 
LH receptor in the thecal compartment (Elvin et al., 2000). GDF-9 increased Inhibin-α su u it 
production in neonatal ovaries (Hayashi et al., 1999) and stimulated Inhibin A and B 
generation by granulosa cells (Roh et al., 2003). 
Also, GDF-9 was shown to be the inducer of progesterone synthesis, where GDF-9 promoted 
progesterone production in differentiated granulosa cells (Vitt et al., 2000, Vitt et al., 2001). 
Study conducted by Yamamoto, et al. on human granulosa cells showed that GDF-9 blocked 
progesterone production induced by cAMP and thereby indicating the variation in the 
mechanism GDF-9 between rat (Vitt et al., 2000) and human (Yamamoto et al., 2002) 
granulosa cells. 
GDF-9 gene expression is predominantly located in the oocytes of neonatal as well as mature 
mouse ovaries (McGrath et al., 1995). Human GDF-9 shared 96% and 77% homology with 
mouse and ovine GDF-9 respectively (Dube et al., 1998, Bodensteiner et al., 1999). Oocytes 
from female mice with GDF-9 gene deletions show faster growth; however, the follicle growth 
is arrested at primary follicle stage (Carabatsos et al., 1998). Granulosa cells from knockout 
female mice also lose their mitotic capacity at later stages of the primary stage (Shimasaki et 




Table 2-3: Knockout phenotypes of phenotypes of several members of the BMP Signalling   
pathway 
Sourced from (Beederman et al., 2013) 
 
2.3 BMP Signal Transduction 
When a BMP ligand binds to the BMP receptor, the type II receptor trans -phosphorylates the 
type I receptor at an intracellular juxtamembrane site rich in glycine and serine residues 
named the GS domain (Wrana et al., 1992). Consequently, the type I receptor Trans-
phosphorylates the R-Smads signalling   proteins: Smad 1,2,3,5 and 8 (Ten Dijke et al., 
2002).The activated R-Smad proteins bind together in multiple protein complexes with Smad-
4 (also termed as the common mediator Smad or Co-Smad) (Nishimura et al., 1998, Massague 
et al., 2005). The R-Smad–Co-Smad complex then moves to the nucleus. Inside the nucleus 
these complexes, which then bind to specific areas of DNA and collaborate  with particular 
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transcription factors where they regulate the activity of target genes and thus control cell 
responses such as  proliferation (Shimasaki et al., 2004). There are significant differences in 
the Smad signalling   pathways of the BMPs and that of activins/TGF-βs (Miyazawa et al., 
2002). Activins and TGF-βs regulate the i tra ellular sig als through the phosphor latio  of 
Smad-2 and Smad-3 whereas almost all BMP (BMP-2, BMP-4, BMP-6, BMP-7 and BMP-15; 
GDF-5 and MIS) ligands mediate their intracellular signals through the phosphorylation of 
Smad-1, Smad-5 and/or Smad-8 (Shimasaki et al., 2004). Figure 2-2 provides a detailed 
description of the BMP signal transduction pathway. Further research illustrated that both 
BMPs as well as Activins can bind to ActR-II and ActR-IIB, hence the major determinant of 
Smad signalling   is dependent on the specificity to binding to type-I receptors (Attisano and 
Wrana, 2002). 
 
Figure 2-2: BMP signal transduction pathway. 
 Sourced from: (Marquis et al., 2009) 
Further validation of the studies has shown that high expression of active forms of BMP-type 
I receptors leads to the activation of Smad-1, Smad-5 and Smad-8, and induction of BMP-
specific biological responses (Chen et al., 1997). On the other hand, GDF-9 was shown to 
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phosphorylate Smad-2 rather than Smad-1/5/8 in human granulosa cells (Kaivo-Oja et al., 
2003).    
2.4 Factors affecting BMP signaling    
BMP signalling is controlled and regulated at various levels by intracellular as well as 
extracellular factors (Rossi et al., 2015). The factors that alter and modulate BMP signalling  
include the Inhibitory Smads that block BMP signalling, the BMP binding proteins that inhibit 
BMPs from binding to receptor and many other factors that utilize different mechanisms 
(Massague et al., 2005).  
2.4.1 Intracellular regulatory Factors 
One of the major regulatory intracellular factors of BMP signalling is the transmembrane 
glycoprotein BAMBI (BMP & Activin Membrane Bound Inhibitor), which is expressed in the 
granulosa as well as the theca cells of the ovary (Luo et al., 2012, Loveland et al., 2003, 
Onichtchouk et al., 1999). The extracellular domain of BAMBI is similar to that of type I 
receptors of BMPs, which could compete for various BMP ligands. However, unlike the BMPR, 
the intracellular kinase domain is absent (Onichtchouk et al., 1999). The absence of such 
intracellular kinase domain of BAMBI fails to form receptor complexes necessary for further 
signalling events (Onichtchouk et al., 1999) hence negatively modulates the BMP signalling. 
Thus, BAMBI can bind to the ligands and block the signalling of BMPs to act as a dominant 
negative receptor (Grotewold et al., 2001).   
The Ski and Tob proteins are other intracellular regulatory factors of BMP signalling in both in 
vivo and in vitro(Wang et al., 2000). The Ski and Tob proteins inhibit BMP signalling by binding 
to the MH2 domain of Smads (Yoshida et al., 2000). Nonetheless, the Ski and Tob proteins  
may not be involved in reproduction, since the Ski and Tob knockout mice exhibited no 
phenotypic defects associated to reproduction (Berk et al., 1997).    
The Smad Ubiquitination Regulatory Protein-1 (Smurf 1) is an intracellular factor that 
negatively regulates BMP signalling by interacting with R-Smads to block BMP signal 
transduction (Zhang et al., 2001). Smurf 1 inhibits BMP signalling by blocking the Smad 1 and 
Smad 5, thereby, leading to their proteosomal destruction (Zhu et al., 1999). Smurf 1 was 
shown to reduce the intracellular levels of Smads, independent of BMP ligand activation 
pathways (Zhu et al., 1999).  
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2.4.2 Extracellular regulatory Factors 
BMP signalling is also regulated extracellularly by various BMP binding proteins and BMP 
ligands. These proteins inhibit BMP signalling by blocking the access of ligands to their 
respective receptors (Gamer et al., 2005). Follistatin, Gremlin and Noggin are several such 
examples of extracellular proteins that inhibit BMP signalling(Ali and Brazil, 2014). BMP 
signalling may also be modulated by the MAPK family of signalling molecules such as ERK 1/2, 
p38 and stress-activated protein kinase/Jun N-terminal kinase (Yamaguchi et al., 1995, 
Nakamura et al., 1999). MAPK signalling molecules were shown to act both as stimulators of 
BMP signalling (Gallea et al., 2001) or inhibitors of Smad signalling pathways (Kretzschmar et 
al., 1997). 
Follistatin, extracted from bovine and porcine ovarian follicle fluid, is another extracellular 
factor that plays a vital role in BMP signalling (Iemura et al., 1998). Follistatin expression was 
observed in nearly all human tissues predominantly in adult ovary, pituitary gland, kidney, 
fetal heart and liver (Tortoriello et al., 2001). Follistatin is capable of binding to several 
members of the TGF-β superfa il , i ludi g BMPs (Iemura et al., 1998) such as BMP-4 
(Yamaguchi et al., 1995), BMP-7 (Iemura et al., 1998) and BMP-15 (Otsuka et al., 2011). 
However, it had antagonizing effect on the BMP-2 induced osteoblast differentiation (Abe et 
al., 2004). In addition, female mice overexpressing follistatin showed smaller size ovaries due 
to the inhibitory function in folliculogenesis (Guo et al., 1998).     
Inhibin, a member of the TGF-β superfa il , is a other e tra ellular fa tor that regulates BMP 
signalling (Shimasaki et al., 2004). Inhibin blocks the FSH secretion in anterior pituitary cell 
cultures from human follicle fluids (Chari et al., 1979). It was hypothesized that Inhibins act 
as competitive inhibitor with the BMPs for the binding to activin type II receptors for inhibition 
of BMPs induced responses (Wiater and Vale, 2003). Thus, Inhibin was shown to block the 
actions of both BMP-2 and BMP-7 (Wiater and Vale, 2003).    
Gremlin encodes extracellular factor that modulates BMP signalling by selectively inhibiting 
the BMP-4 related functions (Shi et al., 2001). Gremlin contained a structural feature that is 
very similar to the cysteine knot present in the TGF-β superfa il  (Hsu et al., 1998).  
Noggin encodes an extracellular factor with BMP antagonistic properties (Smith and Harland, 
1992). Noggin was first discovered for its regulatory function in normal dorsal development 
in Xenopus embryos (Smith and Harland, 1992). Noggin blocks BMP signalling by obstructing 
the binding of type I/type II receptors of BMPs (Groppe et al., 2002). Further researches have 
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shown that Noggin acts as an inhibitory protein for BMP-2, -4, -7, -14 and GDF-5 (Shimasaki 
et al., 2004).  
2.5 The Regulatory role of BMPs in the Ovary  
The impact of the BMPs family on the ovarian function has been demonstrated by using 
different experimental approaches in different animal species. For instance, the 
administration of BMP-7 by Lee et al. to the ovarian bursa of a female rat led to a considerable 
reduction in the number of primordial follicles and a significant increase in the number of 
primary, pre-antral and antral follicles (Lee et al., 2001b). Thus, BMP-7 inhibits the primordial 
follicle formation, however, facilitates follicle development at primary, pre-antral and antral 
follicles in the follicle cycles. In addition, the administration of BMP-7 to rat granulosa cells 
amplified DNA synthesis as well as granulosa cell proliferation (Lee et al., 2001b).  
In a separate study, Vitt et al in 2000 observed enlargement of the ovaries and a significant 
increase in primary and small pre-antral follicles and a reduction in the number of primordial 
follicles due to the administration of GDF-9 to the ovaries of immature rats for several days 
(Similar results were obtained by Shimizu T. et al. (2004) after injecting GDF-9 gene fragments 
to the ovaries of 2-month old pre-pubertal gilts (Shimizu et al., 2004, Vitt et al., 2000). 
In mice, it is well established that primordial germ cell (PGC) determination is induced by the 
extra-embryonic ectoderm in epiblast cells (Saitou et al., 2002). Both BMP-4 as well as BMP-
8b was shown to play vital roles in PGC formation in mouse embryo (Shimizu et al., 2004). The 
genes encoding BMP-4 and BMP-8b were co-expressed in the extraembryonic ectoderm prior 
to the detection of PGCs (Ying et al., 2001). Furthermore, BMP-4 knockout mice were embryo-
lethal during early gastrulation; however, mice which survived gastrulation thrived long 
enough with no later development of the PGCs (Lawson et al., 1999). However, the regulatory 
details of involvement of BMP-4 expression for PGCs are yet to be known.  
Thus, summarily BMP-4 is responsible for the formation of primordial follicles during 
embryonic development. In addition, BMP-4 increase the number of primordial follicles 
developing into primary follicles consequently reduces the number of primordial follicles 
(Nilsson and Skinner, 2003). Also, it reduces the size of the ovaries in whole ovary culture as 




In a study on rat Graafian follicles by Erickson and Shimasaki 2003, the oocyte has been shown 
to express BMP-6, BMP-15, GDF-9, ActR-1A, ActR-II, BMPR-IA and BMPR-IB, the granulosa 
cells showed expression of BMP-2, BMPR-IA, BMPR-IB and BMPR-II, and theca cells showed 
expression of GDF-10, BMP-4, BMP-7, BMPR-IA and BMPR-IB (Erickson and Shimasaki, 2003). 
The BMP-6 mRNA transcripts were shown to be absent in the granulosa cells of the rat 
primordial and primary follicles, which was demonstrated in the dominant follicle (Erickson 
and Shimasaki, 2003). From this result it was concluded that that the elimination of BMP-6 
expression was the trigger for dominant follicle selection in the rat (Shimasaki et al., 2004).  
Studies on experimental mice have illustrated that oocyte derived growth factors act to 
influence FSH-dependant cyto-differentiation in granulosa cells (Otsuka et al., 2011). During 
the development of Graafian follicle, GDF-9 and BMP-15 produced by the oocyte, provide 
gradient signals to produce the different subtypes of granulosa cells , the influence being 
related to their location and distance relative to the oocyte. The different subtypes of 
granulosa cells generated play a critical role in ovulation (Williams and Erickson, 2008). 
In sheep ovaries, BMPR-IA, BMPR-IB and BMPR-II were identified in the granulosa cells of 
primary, antral follicles, the late antral stage, ovarian surface epithelium as well as the corpus 
luteum (Souza et al., 2002). The inhibitory effects of BMP on progesterone production from 
granulosa cells diminished with follicle development (Fabre et al., 2003). Hence such 
inhibitory effects were greater on granulosa cells obtained from small antral follicles than 
from pre-ovulatory follicles (Fabre et al., 2003). On the other hand, activin and TGF-β  had 
similar effects on progesterone production by granulosa cells regardless of the follicle stage 
of follicle development (Fabre et al., 2003). Thus, such an alteration accounted for the effects 
of the BMPR-IB in steroidogenesis, where both BMP-4 and GDF-5 interact with BMPR-IB for 
signalling (Fabre et al., 2003). BMP-4 was demonstrated to block basal and FSH-induced 
generation of progesterone from sheep granulosa cell cultures (Mulsant et al., 2001). 
Moreover, BMP-2 has been illustrated to enhance the production of estradiol from sheep 
granulosa cells (Souza et al., 2002).    
In rat granulosa cell cultures, BMP-7 caused the increase of FSH-induced estradiol production, 
blocked FSH-induced progesterone production (Shimasaki et al., 2004) and enhanced DNA 
synthesis (Lee et al., 2001b). Such effects of BMP-7 on estradiol and progesterone production 
could be the consequence of its effect on P-450 aromatase (converts androstenedione to 
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estradiol) and STAR (transports cholesterol across the mitochondrial membrane) (Lee et al., 
2001b).  
BMP-5 was shown to block basal and FSH induced production of progesterone in rat granulosa 
cell cultures (Pierre et al., 2005) but had no effect on estradiol production (Pierre et al., 2005). 
Such effect of BMP-5 on progesterone production was associated with reduced expression of 
STAR (Pierre et al., 2005). BMP-5 also caused enhanced cyclin D2 expression (protein engaged 
in cell proliferation and differentiation) leading to the production of granulosa cells (Pierre et 
al., 2005). Knockout of Cyclin D2 in female rats resulted infertility because of their granulosa 
cells being unable to proliferate in the presence of FSH (Sicinski et al., 1996).  
BMP-15 was shown to enhance the proliferation and differentiation of granulosa cells, 
independent of FSH induction in rat granulosa cell cultures (Otsuka et al., 2011). BMP-15 
reduces FSH induced progesterone production without affecting the estradiol production 
(Otsuka et al., 2001). Also, reduction of FSH induced expressions of STAR, (LH-R) and (FSH-R) 
by BMP-15 indicated that BMP-15 exerts its effects through up-regulation of cAMP signalling 
(Otsuka et al., 2001). Therefore, BMP-15 reduces both basal and FSH induced expression of 
FSH-R in rat granulosa cell cultures (Otsuka et al., 2001). Hence, BMP-15 could act as a vital 
factor for modulating FSH action by direct action on FSH-R or indirectly by exhibiting its effect 
on different factors such as Follistatin, Inhibin and Activin (Otsuka et al., 2001). Table 2-4 
shows the effects of various members of the TGF-β superfa il , i  ter s of RNA expression, 
in different stages of folliculogenesis (Erickson and Shimasaki, 2003). BMP-6, BMP-15 and 
GDF-9 were expressed in the oocyte of different follicles   (Erickson and Shimasaki, 2003). For 
instance, the expression of both GDF-9 and BMP-15 in the follicle fluid illustrated that they 
were secreted products (McNatty et al., 2006). GDF-9 expression was observed in the oocyte 
of primary and secondary follicles in rats (Jaatinen et al., 1999) and humans (Aaltonen et al., 
1999), whereas is bovine ovaries, GDF-9 was also expressed in the oocyte of primordial 
follicles (Bodensteiner et al., 1999).   
Table 2-4:  The secretory activity of different follicle cell types (m-RNA) of theca cells, granulosa 
cells and oocyte- and its relation to intra-ovarian signaling   molecules, including the BMP family 




In the study conducted by Juengel et al in 2006, BMP-6 mRNA but not BMP-2, BMP-4 or BMP-
7 m RNA was expressed in the non-atretic sheep follicles (Juengel et al., 2006). BMP-6 
expression was confined only to the oocyte of primordial, primary, pre-antral as well as antral 
follicles (Juengel et al., 2006). BMP-2, BMP-4, BMP-6 and BMP-7 each blocked progesterone 
synthesis in granulosa cells of sheep and rat. However, the cellular proliferation and growth 
of the granulosa cells was enhanced in case of the rat, whereas not affected in case of sheep 
indicating differential regulation and species-specific difference for these growth factors 
(Juengel et al., 2006).  
Further studies by Juengel et al. showed that BMP-2, BMP-4 and BMP-7 did not play a role in 
regulating follicle development in sheep ovaries due to the lack of expression of BMP-2, BMP-
4 and BMP-7 in the non-atretic ovarian follicle (Juengel et al., 2006). On the other hand, the 
presence of BMP-6 mRNA in the oocyte provides evidence that BMP-6 may have a paracrine 
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and/or autocrine role in regulating follicle development in sheep, similar to BMP-15 and GDF-
9 (Juengel et al., 2006).  
2.6 Sheep breeds with a high ovulation rate 
Different breeds of sheep possess different ovulation rates. Breeds such as Romanov, 
Booroola Merino, Olkuska, Belcare, Inverdale, Cambridge, Woodlands and Javanese are 
genetically different (Souza et al., 2004, Campbell et al., 2009, Ruoss et al., 2009, Juengel et 
al., 2013). The Booroola Merino ewe is the preferred breed of sheep for experimental analysis 
due to its distinctive characteristics (Bindon et al., 1985). A study conducted by Piper and 
Bindon (1982) postulated that the difference in ovulation rates between Booroola and Merino 
ewes could be contributed by a single major gene (Piper and Bindon, 1983). It was later 
discovered in segregation studies that the Booroola phenotype is due to a mutation in the 
autosomal gene called FecB (Montgomery et al., 1993). 
Higher prolificacy and ovulation rates in homozygous Booroola ewes were shown to be 
related to FecB gene (Hua and Yang, 2009). Introduction of FecB gene to low prolific breeds 
of sheep clearly showed an improvement in the reproductive rate (Hua and Yang, 2009). 
Further research conducted by Wilson et al. on the Booroola phenotype discovered the 
mutation Q249R in the intracellular kinase signalling domain of BMPR-IB, which was 
responsible for the receptor specific for binding to BMP-4 and GDF-5 (Wilson et al., 2001). 
The point mutation Glutamine 294 Arginine in the intracellular kinase signalling domain 
converted the non-carrier ewes to in carrier ewes of Booroola phenotype was caused due to 
alteration in the encoded BMPR-IB protein (Wilson et al., 2001). The granulosa cells from 
Booroola ewes were less sensitive to BMP-4 and GDF-5 with regards to inhibition of 
progesterone production (Fabre et al., 2003). In other words, the mutation in the Q249R 
caused a reduction in the BMP-dependent functions of the BMPR-IB receptor (Shimasaki et 
al., 2004).  Further research by Ruoss et al. on Booroola and Merino whole sheep ovaries at 
birth, 1.5 years and 5 years demonstrated that Booroola sheep ovaries at birth had a 
considerably lower number; however, at 1.5 years and 5 years showed a reversed pattern 
with a considerably higher number of primordial follicles than Merino sheep ovaries (Ruoss 
et al., 2009) (Figure 2-3). Moreover, the rate of primordial follicle recruitment was 
significantly lower in Booroola ewes compared to Merino ewes (Ruoss et al., 2009). As such, 
51% and 66% of primordial follicle consumption took place in Booroola ewes at 1.5 and 5 
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years respectively compared to 92% and 97% of primordial follicle consumption in Merino 
ewes at 1.5 and 5 years (Ruoss et al., 2009). 
 
Figure 2-3: Number of primordial follicles in Booroola/Merino sheep at birth, 1.5 years and 5 years.    
Sourced from: (Ruoss et al., 2009) 
2.7 The impact of mutation of functional (BMPs) on female reproduction  
Mice with targeted deletion of functional BMP genes were lethal prior to the development of 
the reproductive system (Zhao, 2003). For example, the deletions of BMP-2 and BMP-4 genes 
were embryonic lethal due to significant abnormalities in amnion/chorion/cardiac 
development (Zhang and Bradley, 1996) and the lack of mesoderm induction (Winnier et al., 
1995) respectively. However, few mice with targeted deletions of BMP genes deleted 
remained viable albeit reproductive defects and abnormal fertility (Shimasaki et al., 2004). 
BMPR-IB expression was observed in the oocyte of maturing follicles, the oocyte and 
granulosa cells of antral follicles as well as in the uterine endometrium (Yi et al., 2001). On 
the other hand, BMPR-IB was absent in the granulosa cells of atretic follicles and in the 
pituitary gland (Yi et al., 2001). Thus, the absence of BMPR-IB in the pituitary gland indicated 
that BMPR-IB had no direct role in regulation of gonadotropin hormones production (Yi et al., 
2001). In Booroola sheep, BMPR-IB mutation resulted in ovarian follicles undergoing 
premature maturation, thereby leading to three to seven follicles ovulating at smaller 
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diameters compared to their counterparts (Marino sheep) with normal BMPR-IB expression 
(McNatty et al., 2005).  
Deletion of BMPR-IB gene resulted in infertility and disrupted estrous cycles without affecting 
ovarian follicular development in female mice (Yi et al., 2001). Moreover, the Cumulus Oocyte 
Complex (COC) of BMPR-IB knockout mice had less cumulus cells than the COC of control 
mice. These results indicated that the inability of BMPR-IB knockout mice to exhibit cumulus  
cell expansion was the reason for their infertility and infertility initiated after ovulation (Yi S. 
et al., 2001). The findings were supported by the fact that oocytes were capable of undergoing 
fertilization in vitro but not in vivo. Thus, the BMPR-IB mutation has potential implications to 
reduced ability to block the differentiation of follicular cells by the various BMPs (McNatty et 
al., 2005). 
In sheep, the five point mutations in BMP-15 and one-point mutation in GDF-9 gene were 
believed to result reduced levels of mature protein and distorted binding to cell -surface 
receptors. Sheep heterozygous for the GDF-9 and/or BMP-15 mutations showed higher 
ovulation rates than their Wild-type counterparts. Conversely, sheep homozygous for the 
GDF-9 and/or BMP-15 mutations resulted infertility due to follicular growth / developmental 
arrest (Functional BMP-15 protein was present exclusively in sheep oocytes from the primary 
stage, whereas GDF-9 protein was found exclusively in oocytes throughout follicular 
development (McNatty et al., 2006). 
A clinical case study by Demirhan et al. (2005) on a 16-year-old girl with homozygous mutation 
of BMPR-IB, encompassing deletion of the extracellular ligand binding domain of BMPR-IB, 
resulted in severe limb malformations, genital anomalies as well as primary amenorrhea. 
Ultra-sonographic investigation further revealed the absence of ovaries as well as a 
hypoplastic uterus. Further endocrinological examination revealed a hyper-gonadotrophic 
hypogonadism syndrome, indirectly indicating ovarian dysfunction in the patient (Demirhan 




2.8 The interplay between gonadotropin and BMP in folliculogenesis 
BMPs play a vital role in mediating folliculogenesis by regulating the actions of FSH in the 
ovary (Miyoshi et al., 2006, Ruoss et al., 2009, Takeda et al., 2012). FSH was shown to induce 
BMPR-IA and BMPR-IB receptor expression, enhance expression of Smad-1 and Smad-5 
proteins, as well as suppress the expression of the inhibitory Smads - Smad-6 and Smad-7 
(Hosoya et al., 2015). Also, FSH was shown to augments BMP-induced Smad-1, Smad-5 and 
Smad-8 phosphorylation. Since overexpression of BMPR-IA and BMPR-IB considerably 
enhances BMP responses, such BMP type I receptors were considered to be the limiting 
factors for the BMP signalling pathway (Miyoshi et al., 2006, Takeda et al., 2012, Hosoya et 
al., 2015). BMP-4 and BMP-2 were shown to increase FSH-induced estradiol and reduce 
progesterone production in rat (Shimasaki et al., 2004) and sheep (Souza et al., 2002) 
granulosa cells respectively. In others studies, it was reported that BMPs block the normally 
gonadotropin induced progesterone production, brought by Forskolin without affecting the 
estradiol production (Miyoshi et al., 2006). BMPs could also modulate steroidogenesis 
downstream to cAMP formation, since cAMP levels induced by Forskolin were not modified 
by BMPs. The FSH-cAMP pathway was closely related and functionally linked to the BMP 
system, hence crucial for the maintenance and development of granulosa cell proliferation 
depends on the FSH-cAMP pathway, which closely related and functionally linked to BMP 
system (Guangqin et al., 2013, Castilho et al., 2014, Hosoya et al., 2015). Moreover, BMPs 
were shown to down regulate FSH receptors, thereby contributing to the maintenance of 
granulosa cell functions by regulating BMP ligands and FSH sensitivity (Wang and Roy, 2009). 
During follicle growth and development, the granulosa cells exhibited FSH receptor and 
proliferated upon FSH stimulation (Shi et al., 2010). LHR expression also increased in the pre-
ovulation stage in the granulosa cells. Hence, the LHR increased the sensitivity of the 
granulosa cells to the LH surge (Shi et al., 2010). Specifically, BMPs down regulate FSH 
receptors expression, thereby contributing to the maintenance of granulosa cell functions by 
regulating the sensitivity to FSH (Wang and Roy, 2009). In contrast, BMP-2 was demonstrated 
to induce FSH receptor expression while reduce the StAR and LH receptor expression in 
human granulosa cells (Shi et al., 2011).  Figure 2-4 depicts the mutual regulation of BMP and 




Figure 2-4: Mutual regulation of the BMP system and FSH signaling   in granulosa cells Sourced 
from (Miyoshi et al., 2006) 
Both BMP-6 (Shi et al., 2009) and BMP-7 (Shi et al., 2010) are expressed in theca and granulosa 
cells, and both increase FSH receptor and decrease LH receptor expression in granulosa cells. 
BMP-15, produced exclusively from the oocytes in the ovary, suppresses FSH activities by 
blocking FSH receptor expression (Otsuka et al., 2001b). Moreover, GDF-9 derived from the 
oocyte also blocks FSH-induced steroidogenesis as well as LH receptor expression in rat 
granulosa cells (Vitt et al., 2000b). Both BMP-15 and GDF-9 are expressed in the oocytes and 
mutations led to the abrupt halt of folliculogenesis in human (Laissue et al., 2006).  
Chen et al. (2009) investigated the expression of BMP-15 and GDF-9 genes in sheep granulosa 
cells treated with FSH. Treatment of sheep granulosa cells with FSH (1-10 ng/ml) alone 
reduced the expression of BMPR-IB (Chen et al., 2009). While, the treatment of sheep 
granulosa cells with FSH (5 ng/ml) and estradiol (E2) (1 ng/ml) enhanced the expression of 
BMPR-IB. Consequently, the study suggested that the expression of BMPR-IB was modulated 
by FSH and E2 in sheep granulosa cells (Chen et al., 2009). 
BMPs were illustrated to play a role in the regulation of FSH production and secretion in the 
pituitary gland (Young et al., 2008). Pituitary cells from Booroola ewes with natural mutation 
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in BMPR-IB secrete less FSH than wild type ewes, in the presence of BMP-2, BMP-4, BMP-6 
and GDF-9 (Young et al., 2008). However, the BMPs did not influence the amount of FSH 
stored in the cells or the levels of secreted LH (Young et al., 2008). Furthermore, the BMPR-
IB receptor was not found to co-exist with gonadotrophin cells in Booroola/Wild-type 
pituitary cell. Thus, the results of the study implicated that the effect of BMP-2, BMP-4, BMP-
6 and GDF-9 does not occur under the direct action of the mutant BMPR-IB receptor in the 
cells that synthesize FSH (Young et al., 2008). 
Despite the well documented evidence present to date of how the BMP system modulates  
FSH action in granulosa cells, a clearer understanding of how FSH modulates the BMP system 
in the ovary is yet to be determined. It remains clear though that FSH actions throughout 
folliculogenesis are strictly modulated by paracrine as well as autocrine factors as the follicles 
grow and develop (Webb et al., 2003).  
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Abstract—Ovarian folliculogenesis is primarily controlled 
by the action of gonadotropins namely follicle stimulating 
hormone (FSH) and luteinizing hormone (LH). Several 
reports indicated that the process of initial recruitment of 
primordial follicles to the growing follicles is not 
gonadotropin-dependent but Bone morphogenetic protein 
(BMP)-dependent. However, this has not been 
unequivocally confirmed. The aim of this study was to 
investigate the temporo-spacial protein expression of the 
BMP receptors 1B (BMPR1b), FSHR and LHR in several 
stages of follicle development. While the localization of all 
receptors was found in granulosa cell membrane of the 
follicles the temporal expression was varied. BMPR1b was 
expressed in all follicle stages, FSHR was detected in 
primary follicles onward and LHR was absent in both 
primordial and primary follicles but appeared in later 
stages. Quantitative analysis based on the intensity of 
fluorescent signals showed that the expression of BMPR1b, 
FSHR and LHR significantly (p< 0.001 p< 0.0001 p< 0.0001 
respectively) increased with follicular development. We 
have concluded that the combination of sensitive 
immunofluorescence labeling and computerized 3D image 
analysis proves efficient tools for in situ detection and 
quantification of the expression of small amount of protein 
in a complex tissue structure.  
 
Index Terms—
follicle stimulating hormone (FSH), luteinizing hormone 
(LH), 3D image analysis 
I. INTRODUCTION 
Ovarian folliculogenesis is the basis of the entire 
ovarian function including the production of mature 
oocytes ready for fertilization and the sexual hormones 
required for the development of female phenotypes. This 
process entails a series of chronological steps in which a 
growing follicle either matures to ovulation or dies by 
apoptosis [1]. The primordial follicle considered as the 
constructional units of female ovary. The initial transition 
of primordial follicles to growing primary follicles is the 
key limiting step in preserving or depletion of the female 
fertility reserve. It is well established that folliculogenesis 
is regulated by the gonadotropins FSH and LH, which are 
secreted by the pituitary gland [2]. In addition, complex 
autocrine and paracrine actions of several intra-ovarian 
factors such as the BMPs influence the action of 
gonadotropins [3]. For instance, it is now believed that 
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the initial stage of follicle recruitment and development 
of primordial to primary follicles is independent of the 
gonadotropins [4] but rather associated with a specific 
spatial and temporal pattern of BMP expression [5].  
However, such interplay between the gonadotropins 
and BMPs particularly in the initial recruitment of 
primordial  
Follicles remain inconclusive. Because of the complex 
nature of the ovarian structure and the dynamics of 
folliculogenesis, most of the studies in relation to this 
issue have been conducted in vitro using molecular and 
biochemical approaches [6] or in situ microscopic 
analysis using manual subjective methods [7].  
The use of new non-bias computerized technology in 
biomedical research has increased in the past decades. 
The computer-based method was introduced to provide 
accurate and reliable quantitative information as well as a 
non-time consuming tool [8]. This technology will 
eventually replace the conventional manual and 
subjective methods. In attempt to clarify the regulation of 
initial folliculogenesis; the present study demonstrates the 
interaction between BMP and gonadotropin signaling 
systems, using immunofluorescence detection and 3D 
image analysis of cell-membrane bound receptors of 
BMPs, FSH and LH in developing follicles of sheep 
ovaries. 
II. MATERIALS AND METHODS 
A. Sample Collection and Histology  
Sheep ovaries were collected from local abattoir and 
divided into 2 groups. One group was snap-frozen in 
liquid nitrogen and stored in -80ºC for further usage.  The 
second group was fixed in 10% Neutral Buffered 
Formalin (NPF) and processed using Tissue-Tek VIP 
automatic tissue processor and embedded into paraffin 
wax. Tissue sections of 5 µm were cut, placed onto super 
frost slides (HD scientific supplies Pty Ltd, Australia) and 
stained with Hematoxylin and Eosin for morphological 
study to identify the different stages of follicular 
development.  
B. Immuonoflourescent Labeling of BMPR1b, FSHR 
and LHR 
Frozen tissues were partially embedded in OCT and 
10µm sections were prepared using a Cryostat (Carl Zeiss, 
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folliculogenesis, Bone morphogenetic protein, 
Sydney, NSW, Australia) and fixed in 4% 
paraformaldehyde at 4ºC for 7 min. Indirect 
immunofluorescence labeling was performed as 
previously reported [9]. In brief, 4µg/ml of the primary 
antibodies was applied overnight at 4ºC in humidified 
chamber. The antibodies are (monoclonal) goat anti-
BMPR1b (sc-5679), goat anti-FSHR (sc-7798) and goat 
anti-LHR (sc-26341), all from Santa Cruz Biotechnology, 
Santa Cruz, CA, USA. After a serial of washing a donkey 
Anti-goat second antibody conjugated with Alexa 488 
(Molecular Probes, Australia) was added for 45 min in 
dark humidified chamber. Negative controls were 
performed by omitting the second antibodies for the 
presence of auto-fluorescent signals and non-specific 
binding. The sections were mounted using anti-Fade 
aqueous mounting medium containing 40, 60-diamidino-
2-phenylindole (DAPI; Molecular Probes, NSW, 
Australia).  
The sections were examined by Carl Zeiss semi-
confocal fluorescent microscope equipped with CarlZeiss 
Digital Camera (200M Axiovert; Carl Zeiss, Sydney, 
NSW, Australia) and the images were captured using 
AsioVision 4.2.8 image analyzer software. 
C. 3D Image Analysis and Immuonoflourescent 
Intensity Quantification 
For image acquiring, the exposure time was adjusted 
using control sections incubated with pre-immune serum 
in order to subtract auto-fluorescent and non-specific 
binding background. Surplus fluorescent signals, 
appeared after such subtraction, were considered specific 
binding, which were subjected for quantification study.  
Z-stalks of 10x1μm optical frames/sections, generated 
from the 10μm thick physical sections, were captured and 
compiled to generate 3D images. The 3D images were 
used to quantify the intensity of immuonoflourescent 
signals in the entire 10μm sections (Fig. 1).  
 
Figure 1.  Granulosa cells from pre-ovulary follicles A. 2D image to 
determine the Localization and receptor expression B. 3D image for 
immuonoflourescent quantification. X40 
D. Statistical Analysis 
Statistical analysis was performed using prism version 
6 (Graph Pad Software, La Jolla, CA, USA). The results 
were analyzed using the mean and standard deviation of 
BMPR-1b, FSHR and LHR expression in four stages of 





A. Morphological Assessment  
Four stages of follicular development have been 
identified and subjected to this study (Fig. 2A-D). 
Primordial follicles (Fig. 2A) consist of a primary oocyte 
surrounded by few spindle-shaped cells, granulosa cells 
(GCs). The primary follicle (Fig. 2B) initially consists of 
a primary oocyte surrounded by a complete layer of 
cuboidal GCs. The zona pellucid (ZP), a thick layer 
composed of glycoprotein and acid proteoglycans, forms 
between the oocyte and GCs. Once GCs proliferate and 
arrange into multiple layers the secondary follicle is 
formed (Fig. 2C). The Graafian follicle is characterized 
by a large, fluid-filled antrum and an eccentric oocyte 
(Fig. 2D).   
 
Figure 2.  Four stages of follicle development A) Primordial follicle B) 
Primary follicle C) Secondary follicle D) pre-ovulatory follicle. 
B. Immuonoflourescent Localization of BMP1b, FSHR 
and LHR  
Immunofluorescence microscopy revealed that the 
intensity of a positive immunolabelling of the membrane-
bound receptors varies based on the stage of follicular 
development with the least signals captured in primordial 
follicles. BMPR1B was expressed in follicular cells of all 
stages (Fig. 3A-D). Immunolabelling of FSHR showed no 
staining in follicle cells of primordial follicles but 
expressed in primary follicles onward (Fig. 3E-H). LHR 
expression was absent in both primordial (Fig. 3 I) and 
primary follicles, which then expressed in later stages of 
follicular development (Fig. 3 I-L).  
 
Figure 3.  The expression of BMPR1b (A-D), FSHR (E-H) and LHR 
(I-L). A, E, I, primordial follicles; B, F, J, primary follicles; C, G, K, 
secondary follicles; D, H, L, Graafian follicles. Green color staining 
indicates a positive labeling of the receptors. E, I and J show negative 
staining of FSHR (E) and LHR (I, J). X40 
C. 3D Image Quantification of BMP1B, FSHR, and 
LHR 
Expression during different follicular stages 
Quantitative analysis based on the intensity of fluorescent 
signals expressed in 3D images showed that the 
expression of BMPR1b, FSHR and LHR significantly (p< 
0.0001) increases with follicular development (Fig. 4A-
C). The intensity of labeling was higher for BMPR1b and 
lower for LHR. BMPR-1b expression was detected in the 
GCs in all follicular stages of follicular development (Fig. 
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4A). The FSHR expression was absent in primordial 
follicles but expressed in the rest stages of follicular 
development (Fig. 4B). LHR expression was absence in 
both primordial and primary follicular and expressed in 
the rest stages of follicular development (Fig. 4C).  
 
Figure 4.  Showed the quantification of receptor expression (pixel/μm2) 
in 4 stages of ovarian development. A) The BMPR1b expression 
B)FSHR expression C) LHR expression, number of follicles n=20.**: 
p<0.001, ***: p<0.0001 
IV. DISCUSSION 
This study demonstrates for the first time the temporo-
spacial localization and quantification of BMPR1b, 
FSHR and LHR in sheep ovaries throughout the initial 
steps of folliculogenesis. The results indicate that 
gonadotropins are not involved in the recruitment of 
primordial follicles clarifying the ambiguity of the 
literatures [10], [11]. In addition, the in situ localization 
of these three receptors in the follicles across several 
stages of development unequivocally shows the interplay 
between these hormones and growth factors in the 
regulation of ovarian function. Traditionally, the 
detection and quantification of immuonoflourescent 
labeling is conducted by manual subjective methods 
presented in form of scores range from 0 (no staining) to 
4 (intensive staining). This kind of studies may be 
subjected to bias and therefore non-reliable particularly 
for the purpose of statistical significance [8]. In addition, 
subjective approach is not efficient to detect and estimate 
a small amount of signals, such as within the cell 
membrane, within a complex structure. Furthermore, 
semi-quantitative method can only estimate signals 
emitted from the surface of a single section, which does 
not represent the actual amount of molecules in the 3D 
tissue structure. The present study provides alternative 
approach using computer-based quantitative analysis of 
3D objects.   
Ovarian folliculogenesis operates mainly under the 
control of FSH and LH; their levels are regulated by the 
hypothalamic-pituitary-gonadal axis [2]. However, it has 
been reported that normal follicle development occurs in 
mice with mutation in FSH β subunit and FSHR [12], 
suggesting that the regulation of initial follicle 
recruitment is gonadotropin-independent [13]. Instead, it 
is now believed that the initial recruitment of primordial 
follicles is a gonadotropin-independent process but 
controlled by intraovarian factors [14] such as the BMPs 
[15], yet other conflicting reports indicated otherwise 
[10], [16] 
In this study, the absence of FSHR and LHR in 
primordial follicles unequivocally indicates that the early 
stage of follicular development is gonadotropin 
independent. However, the precautious expression of 
FSHR in primary follicles suggested that FSH may be 
involved indirectly by up-regulating the expression of 
BMPR1b [6]. 
V. CONUCLUSION 
The current study highlights the necessity and 
feasibility of using non-bias computerized method to 
detect and quantify the presence and distribution of a 
small quantity of molecules in a 3D complex structure 
such as the ovarian follicles. The outcome of the study is 
important in expanding our understanding of the role of 
BMPs in the regulation of ovarian functions. 
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Abstract
The primordial follicle reserve is the corner stone of female fertility and determines the longevity and quality of reproduction.
Complete depletion of this reserve will lead to primary infertility, and the key-limiting step of follicle depletion is the transition
from primordial to primary follicles. It has been reported that this process is gonadotrophin-independent, but other conflicting
reports are indicated otherwise and this discrepancy needs to be unequivocally clarified. The aim of this study was to investigate
the role of bone morphogenetic proteins (BMPs) in the regulation of folliculogenesis in mice passively immunised against BMP
receptor 1B (BMPRIB) and BMP4. While a stereological study revealed that the numbers of primordial follicles in immunised mice
were significantly higher when compared with control animals, treatment with equine chorionic gonadotrophin showed no effect.
In parallel, immunofluorescence microscopy revealed the presence of BMPRIB but not FSH receptor in primordial follicles.
The number of primary follicles in immunised mice were also significantly increased when compared with control animals.
After puberty, the rates of depletion of primordial and primary follicles were increased with age, particularly in treated animals;
however, there was no significant difference between the treatment groups of the same age. Based on these results together with
our previous reports in sheep and mice, we confirm that the attenuation of BMP signalling system can be an effective approach
to sustain the primordial follicle reserve while promoting the development of growing follicles, ovulation and consequently overall
female fertility.
Reproduction (2015) 149 403–411
Introduction
In the ovary, primordial follicles contain arrested primary
oocytes, which remain viable throughout life. Among
other factors, the numbers and quality of these follicles
determine the longevity of female fertility. Every day a
few primordial follicles begin development into primary
follicles, of these only a small fraction will be destined to
complete full folliculogenesis and ovulate, while all the
rest die via atresia at some point along the follicular
development pathway (McGee & Hsueh 2000). This
process of continuous follicular atresia with age and
repetition of ovulation after puberty results eventually in
complete depletion of this fertility reserve and hence the
cessation of ovarian function in mammals and specifi-
cally menopause in women. Therefore, the initial
transition from primordial to primary follicles, also
known as initial follicle recruitment (McGee & Hsueh
2000, Depalo et al. 2003, Thomas & Vanderhyden
2006), is the key limiting step of folliculogenesis and
thus follicle depletion.
Ovarian folliculogenesis operates mainly under the
control of gonadotrophins (follicle-stimulating hormone
(FSH) and luteinizing hormone (LH)), whose levels are
regulated by the hypothalamic–pituitary–gonadal axis
(Fauser & Van Heusden 1997). Specifically, it has been
commonly believed that FSH may be involved in the
initial recruitment of primordial follicles (Meredith et al.
1992, Flaws et al. 1997). However, recent observations
have demonstrated that these follicles develop normally
in mice lacking active FSH or FSH receptor (FSHR) due
to gene mutation in FSH b subunit (Siegel et al. 2013) or
FSHR (Dierich et al. 1998), suggesting that initial follicle
recruitment is gonadotrophin independent (Orisaka
et al. 2009). Instead, this process appears to be regulated
by several intraovarian factors (Tanwar et al. 2008), such
as the bone morphogenetic proteins (BMPs) (Lee et al.
2001, Knight & Glister 2003, Abir et al. 2008), and this
discrepancy requires further investigation.
BMPs are members of the TGF-b superfamily and
signal through their serine/threonine kinase receptors
(Massague 1998), which are of two types: type I
q 2015 Society for Reproduction and Fertility DOI: 10.1530/REP-14-0451
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(BMPRIA and BMPRIB) and type II (Cheifetz et al. 1987,
Chang et al. 2002, Derynck & Zhang 2003). The BMP
signalling system comprises several BMP ligands, BMPR
type I and II, and the intracytoplasmic transcription
factors SMADs (Shimasaki et al. 2004).
BMP4 mRNA is primarily expressed in theca cells,
whereas BMPRIB is predominantly expressed in the
granulosa cells of rat ovaries (Shimasaki et al. 1999,
Erickson & Shimasaki 2003, Tanwar & McFarlane 2011),
indicating a paracrine mode of action. BMPRIB is the
main and common receptor used by several intraovarian
BMPs such as BMP 2, 4, 7, and 15 (Shimasaki et al.
2004). On the other hand, the dominant intraovarian
BMP4 exerts a major role in the formation of primordial
germ cells (oocytes) (Shimasaki et al. 1999, 2004),
recruitment of primordial to primary follicles in sheep
(Ruoss et al. 2009) and rat (Nilsson & Skinner 2003),
oestradiol production, and inhibition of progesterone
secretion and ovulation (Lawson et al. 1999, Shimasaki
et al. 1999, Nilsson & Skinner 2003, Ruoss et al. 2009).
In rodent models, the role of BMPs in initial follicle
recruitment and overall ovarian function has been
investigated, including in vitro culture of mouse
follicular cells (Shimasaki et al. 2004) and cultured
whole ovaries of rat (Nilsson & Skinner 2003). We have
supported these in vitro studies using in vivo models
namely the Booroola sheep (Ruoss et al. 2009) and
mice passively immunised against BMP4 (Tanwar et al.
2008), both models are characterised by attenuated
action of the BMP signalling system, similar to that
initially described in Bmp4lacZneo haplo-insufficient mice
(Lawson et al. 1999). Our recent report has confirmed
that the attenuation of the BMP signalling system by a
natural point mutation of BMPRIB in Booroola sheep
reduces the rate of primordial follicle recruitment, while
increasing primary follicle survival (Ruoss et al. 2009).
However, it has not yet been determined whether such
an effect of BMPs is a sheep species and/or a Booroola
strain specific phenomenon or can be applied to other
species and different experimental conditions. Although
we have confirmed the role of BMP4 in primordial
follicle recruitment in mice after passive immunisation
(Tanwar et al. 2008), this preliminary report was based
only on immediate observations after a short-term
treatment and using manual counting of follicles.
The aim of this study was to investigate the role of the
BMP signalling system in the regulation of primordial
follicle depletion in an in vivo model of mice passively
immunised against BMPRIB and BMP4, using a
computer-based stereological method (Braendgaard &
Gundersen 1986, Myers et al. 2004, Ruoss et al. 2009).
Specifically, the study aimed to quantify the numbers of
primordial and primary follicles and calculate their ratios
in different treatment and age groups of mice. The role
of gonadotrophins and their interaction with the BMP




Antibodies to BMP4 (JMCK#54) and BMPRIB (JMCK#59) were
raised in chickens against synthetic peptides (Invitrogen
Australia) equivalent to amino acids 88–102 (ISMLYL-
DEYDKVVLK) of mouse BMP4 and amino acids 103–117 of
mouse BMPRIB (NKDLHPTLPPLKDRD). The antibodies were
raised and characterised in our laboratory as described
previously (Tanwar & McFarlane 2011). In brief, the synthetic
peptides were conjugated to diphtheria toxoid (CSL) and
emulsified in Freunds complete adjuvant (Sigma–Aldrich Pty
Ltd) for the primary vaccination and in Freunds incomplete
adjuvant for booster injections. The primary vaccination
contained 50 mg of peptide, while all boosters contained
25 mg of peptide. The antibodies were purified from egg yolks
using a combination ammonium sulphate and octanoic acid
as described by McKinney & Parkinson (1987). The cross
reactivity of BMP2 and BMP7 was !0.5% for the anti-BMP4
antibody and the specificity of the BMPRIB antibody was
determined by competitive binding ELISA test against random
peptides (Tanwar & McFarlane 2011). The DELTA-BLAST
analysis showed that the sequence was specific to mouse
BMPRIB with no potential binding to other proteins. These
antibodies were used to passively vaccinate mice using 50 mg
of purified antibody in 100 ml of saline injected subcu-
taneously. The dose of antibody was similar to that we have
used previously (Tanwar et al. 2008) and was determined by
pilot studies.
Animals and passive immunisation
Female Swiss mice at 21 days of age were housed at the
Physiology Animal House facility, University of New England,
NSW, Australia, where all the in vivo experiments were carried
out in accordance with the Australian code of practice for the
care and use of animals for scientific purposes, and approved
by the University of New England Animal Ethics Committee.
To investigate the effects of attenuating the BMP signalling
system on follicle developmental dynamics in the presence
and absence of exogenous gonadotrophins, 3-week-old female
mice were divided into six groups (nZ4 each group) and daily
s.c. injections (100 ml) of the following treatments were given
for 7 days: the first group, 50 mg anti-BMP4 (nZ20); the second
group, 50 mg anti-BMPRIB (nZ20); the third group, 1 IU
equine chorionic gonadotrophin (eCG; Bioniche Animal
Health, Armidale, NSW, Australia) (nZ4); the fourth group,
1 IU eCGCanti-BMP4 (nZ4); the fifth group, 1 IU eCGCanti-
BMPRIB (nZ4); and the sixth group, 50 mg purified non-
immune chicken IgY, as a control group (nZ20). Four mice of
each group were killed by CO2 asphyxiation 24 h after the last
injection. The remaining animals of first, second, and sixth
groups were kept for further periods of 2, 6, 12, or 24 weeks
without treatment before they were killed at 6, 10, 16, or 28
weeks of age respectively (nZ4 for each group). The total
number of animals used per each full experiment was 72 and
this experiment was repeated three times (216 mice in total).
However, only 72 animals (four animals per treatment group
per age), randomly selected from the three experiments, were
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used in this study. All other animals were kept for other
investigations. The ovaries were collected and used for further
studies as detailed below.
Ovaries and histology
The collected ovaries were dissected to remove excess
surrounding tissues and one from each animal was fixed in
Bouin’s solution, paraffin embedded, and processed for
histological study. The whole ovaries were exhaustively cut
into at 5 mm serial sections using a rotary microtome. The
sections were consecutively labelled, mounted on a glass
slide and stained with haematoxylin and eosin for further
stereological studies. For this purpose, the stages of follicle
development were classified according to previous reports
(Myers et al. 2004, Ruoss et al. 2009). In brief, primordial
follicles appeared as a primary oocyte surrounded by a single
layer of squamous granulosa cells (Fig. 1, inset), whereas
primary follicles showed a complete single layer of cuboidal
granulosa cells (Fig. 2, inset). The same serial sections were
used to count the numbers of corpora lutea in each ovary for
the determination of relative ovulation rate. Five other
ovaries each that represents the five different ages of control
animals were used for immunofluorescence studies of
receptor expression. These ovaries were snap frozen in liquid
nitrogen and stored at K80 8C before they were cryo-
sectioned for immunofluorescence localisation of BMPRIB
and FSHR.
Stereology of ovarian follicles
The estimated total numbers of primordial and primary follicles
in the entire ovary were counted by the physical dissector
method as originally described (Braendgaard & Gundersen
1986, Gundersen et al. 1988). Every 10th section (50 mm
interval) selected in the order generated by the microtome
was used to provide a non-biased representation for the
whole ovary. The section boundaries were determined under
low magnification for the placement of the 150!150 mm
(22 500 mm2) sampling grid, and the section sampling was
performed as previously described (Myers et al. 2004) to
generate 32–72 sampling frames. Follicle counting was done
using !40 oil immersion objective (NAZ1.0), fitted to an
Olympus BX microscope. The microscope supported by a
computerised Stereo Investigator station (Stereo Investigator
software version 8, MicroBrightField, Inc., Colchester, MA,
USA) was used for the data collection and analysis. The
procedure of follicle counting has been fully described
previously (Ruoss et al. 2009).
Estimation of ovulation rates
The estimation of ovulation rates in mice from different
treatment groups was carried out by counting the numbers of
(new and old) corpora lutea present in each selected ovary,
obtained from treated and control animals of 4, 10, and 16










































































































Figure 1 Stereological quantification of primordial follicles in different
treatment groups. The estimated follicle number per ovary was
calculated in every 10th section (50 mm interval) using a computerised
stereological method. The meanGS.D. of the estimated total number of
primordial follicles per ovary was significantly higher in mice
passively immunised compared with controls at most ages as
indicated. At week 4, eCG treatment either alone or in combination
with antibodies showed no difference compared with controls.
**P!0.01; ****P!0.0001. Inset, a group of primordial follicles















































































































Figure 2 Stereological quantification of primary follicles in different
treatment groups. The estimated follicle number per ovary was
calculated in every 10th serial section (50 mm interval) using a
computerised stereological method. The meanGS.D. of the estimated
total number of primary follicles per ovary was significantly higher in
mice passively immunised with anti-BMPRIB compared with control
group at all animals ages. In mice immunised with anti-BMP4, a
significant difference was found up to age 10 weeks. At week 4, eCG
treatment with or without antibodies revealed significant reduction
in primary follicle numbers. *P!0.05; **P!0.01; ***P!0.001;
****P!0.0001. Inset, a primary follicle shows an oocyte (O) surrounded
by a complete layer of cuboidal granulosa cells. BarZ50 mm.
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were counted in every 40th section of the ovaries, in the order
generated by the microtome, leaving 200 mm intervals that are
slightly larger than the average size of individual corpus luteum
in mice ovaries (Sandrock et al. 2009). This method provides
a non-biased representation of the whole ovary and avoids
multiple counting of the same corpus luteum.
Immunofluorescence localisation of receptors
The ovarian cryosections (10 mm) were mounted on Superfrost
slides (HD Scientific Supplies Pty Ltd, Australia) and used for
indirect immunofluorescence labelling as described previously
(Hall & Almahbobi 1997, Al-Samerria & Almahbobi 2014).
Briefly, the tissue sections were fixed in 4% paraformaldehyde,
and polyclonal goat anti-BMPRIB (sc-5679) and anti-FSHR
(sc-7798) (Santa Cruz Biotechnology) were applied at 4 mg/ml
overnight at 4 8C. For the negative control, the tissue sections
were incubated with 10% (v:v) pre-immune goat serum (Life
Technology) instead of primary antibodies. A polyclonal rabbit
anti-goat IgG second antibody conjugated to Alexa 488
fluorochrome (A-11078, Life Technology) was applied to all
slides at 4 mg/ml for 45 min at room temperature. The slides
were washed and mounted in Prolonged Diamond anti-fade
mounting media with DAPI (P-36962, Life Technology). The
slides were examined using a Carl Zeiss semi-confocal
microscope equipped with a Carl Zeiss Digital Camera 200
M Axiovert (Carl Zeiss, Sydney, NSW, Australia) and images
were captured using AsioVision 4.2.8 image analyzer software
(Carl Zeiss).
Calculation and statistical analyses
Statistical analysis was performed using two-way ANOVA
followed by Tukey’s post hoc test for multiple comparisons to
compare the estimated numbers between control and treated
animal groups in Prism version 6 (Graph Pad Software, La Jolla,
CA, USA) and the data were presented as GS.D. The differences
between means were considered significant when P!0.05.
The ratios of primordial and primary follicle numbers in
different ages of animals were calculated as the percentages
of follicle numbers at a given age relevant to the numbers of
follicles in animals of the same treatment group at week 4 of
age, as given in Tables 1 and 2.
Results
Stereological quantification of primordial and primary
follicles in different ages
Regardless of treatment, the overall mean of estimated
total numbers of primordial and primary follicles per
ovary significantly decreased with age, with a noticeably
sharp reduction at the later age of animals. Specifically,
at the 28th week of age, the follicle numbers were
significantly (P!0.0001) reduced in each individual
treatment group when compared with those at week 4
(Tables 1, 2 and Figs 1, 2). Only 16–27 and 29–39% of
the primordial and primary follicles, respectively, were
found in mice at week 28 of age compared with those at
week 4. The reduction in follicle amount showed no
significant difference neither between the two immu-
nised animal groups nor between the immunised and
control animals (Tables 1 and 2).
Stereological quantification of primordial follicles
in different treatment groups
The estimated total numbers of primordial follicles in
animals immediately after treatment with anti-BMPRIB
and anti-BMP4 antibodies at 4 weeks of age were
significantly (P!0.0001) higher (205 and 177%, res-
pectively) than that in control mice (Fig. 1). The numbers











Treatment MeanGS.D. Ratio MeanGS.D. Ratio (%) MeanGS.D. Ratio (%) MeanGS.D. Ratio (%) MeanGS.D. Ratio (%)
Control 3290G37 NA 3025G167 92 2663G40 81 1329G99 40 878G57 27
Anti-BMPR1B 6741G185 NA 5183G116 77 5679G198 84 1939G85 29 1070G75 16
Anti-BMP4 5831G281 NA 4893G86 84 4509G193 77 1517G137 26 989G53 17
The ratios of primordial follicles, expressed as a percentage of the estimated total numbers at a given age to the numbers at week 4, gradually
decreased with age. There was no significant difference in the ratio of follicle loss between the different groups of treatment at a given age.
n, number of animals.











Treatment MeanGS.D. Ratio MeanGS.D. Ratio (%) MeanGS.D. Ratio (%) MeanGS.D. Ratio (%) MeanGS.D. Ratio (%)
Control 254G12 NA 232G15 91 149G9 59 130G8 51 100G12 39
Anti-BMPR1B 444G8 NA 412G32 93 334G9 75 193G9 43 139G10 31
Anti-BMP4 438G13 NA 382G17 87 300G11 68 151G14 34 127G13 29
The ratios of primary follicles, expressed as a percentage of the estimated total numbers at a given age to the numbers at week 4, gradually decreased
with age. There was no significant difference in the ratio of follicle loss between the different groups of treatment at a given age. n, number of animals.
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remained significantly (P!0.0001) higher at 6 and 10
weeks, but showed a sharp reduction in older animals.
Although the numbers were still elevated in both treated
groups beyond week 10, a significant difference
(P!0.01) was only observed in animals treated with
anti-BMPRIB at 16 weeks of age. At 4 weeks, there
was no difference in the numbers of primordial follicles
between the control and those animals treated with
eCG. However, treatment with eCG abolished the
immunisation-induced higher numbers of primordial
follicles (Fig. 1).
Stereological quantification of primary follicles in
different treatment groups
Analysis of these data showed that the estimated total
numbers of primary follicles in animals immediately
after treatment with anti-BMPRIB and anti-BMP4
antibodies at 4 weeks were significantly (P!0.0001)
higher (175 and 172% respectively) than that in control
mice (Fig. 2). In animals treated with anti-BMPRIB, the
numbers of primary follicles remained significantly
higher at 6 (P!0.001), 10 (P!0.001), 16 (P!0.01)
and 28 (P!0.05) weeks. In animals treated with anti-
BMP4, the numbers of primary follicles remained
significantly higher at 6 (P!0.01) and 10 (P!0.001)
weeks, but no significant difference was found at 16
and 28 weeks (Fig. 2).
In contrast to the case of primordial follicles, treatment
with eCG alone or as a supplement with anti-BMPRIB
significantly reduced (P!0.0001, 59%) the estimated
numbers of primary follicles at 4 weeks. Similar
results were observed after treatment with anti-BMP4
(P!0.01) (Fig. 2).
Immunofluorescence localisation of BMPR1B and FSHR
Immunofluorescence observation revealed positive
staining for BMPRIB in both primordial and primary
follicles, as well as in the stromal cells (Fig. 3C, G and
H). Staining of FSHR showed positive labelling only in
the granulosa cells of primary follicles (Fig. 3F), but not
in primordial follicles (Fig. 3B). The negative control
specimen using pre-immune serum instead of primary
antibodies against BMPRIB or FSHR showed no staining
in either follicular or stromal cells (Fig. 3D).
Ovulation rates
A considerable increase in ovulation rate relative to age
was observed in all animals irrespective of the types
of treatment, particularly in control animals (Fig. 4A).
Treatment with eCG revealed a significant increase in
ovulation rate at 4 weeks of age when given alone
(P!0.0001), with anti-BMPRIB (P!0.001) or with anti-
BMP4 (P!0.01) (Fig. 4A). Treatment of animals with
anti-BMPRIB resulted in a significant increase in
ovulation rates at 4 (P!0.0001), 10 and 16 (P!0.05)
weeks when compared with control animals (Fig. 4A, B
and C). However, although treatment with anti-BMP4
resulted in elevation in ovulation rate across the ages,
this was not significant (Fig. 4A).
Discussion
This study describes how short-term attenuation of the
BMP signalling system (1 week) by passive immunisation
against BMPRIB and BMP4 can sustain the reserve of
primordial follicles while increasing the numbers of
developing primary follicles and the rate of ovulation in
pre-pubertal mice in vivo. Together with our previous
reports (Tanwar et al. 2008, Ruoss et al. 2009), we extend
our knowledge regarding the role of the BMP signalling
system in the regulation of follicular development. This
includes the stimulatory role of these factors in the initial
recruitment of primordial follicles to the pool of growing
follicles in the rat (Nilsson & Skinner 2003) and sheep
(Ruoss et al. 2009), also their stimulatory role in the
ovulation rate and formation of primordial germ cellsand
oocytes as previously documented (Moore et al. 2004,
Lawson et al. 1999, respectively).
In this study, the resulting changes induced by passive
immunisation against the BMP signalling system on both
the initial recruitment of follicles and ovulation rate
remained for several weeks after treatment. Considering
the short half-life of IgG antibody, such an extended
effect for several weeks after immunisation was unlikely




























Figure 3 Immunofluorescence localisation of BMPR-IB and FSHR.
(A) A histological section stained with H&E, showing a group of
primordial follicles. (B and C) Groups of primordial follicles showing
negative staining for FSHR (B) and positive staining for BMPRIB in
follicular cells (C, green). (D) A negative control section using pre-
immune serum showing no receptor staining. (E, F, G and H) Primary
follicles reveal positive staining (green) for both FSHR (F) and BMPRIB
(G) in granulosa cells. (E) A primary follicle, as shown in (F), observed
with a single filter for DAPI, revealing nuclear staining (red) only.
(H) A primary follicle, as shown in (G), observed with a single filter
for Alexa 488, revealing only positive receptor staining (green) in
granulosa and stroma cells. Arrows indicate follicular/granulosa cells
stained with DAPI (red). Arrowheads point to positive signals of
antibody binding (green). O, oocyte. BarZ50 mm.
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Instead, we believe that the immediate significant
increase in primordial follicle population in treated
animals compared with controls would have taken
several weeks before it was abolished and returned to
the normal condition. It is also possible that the
noticeably higher magnitude of age-related acceleration
of ovulation rate in control animals compared with the
treated ones would have over-ridden the significant
difference in ovulation rates between the two groups of
animals at later ages. These results are similar to those
observed in Booroola sheep (Ruoss et al. 2009).
However, the receptor mutation-induced effect in
sheep is permanent, resulting in an increased longevity
of reproduction (Ruoss et al. 2009). In our passive
immunised mouse model, the effect is transitory so when
the ‘effector’ is removed the system returns to normal.
Nonetheless, the exact intracellular pathway that
mediates the effect of passive immunisation on BMP
signalling system needs to be clarified.
Interestingly, the effect of immunisation on the
preservation of primordial follicles and increasing
ovulation rates using anti-BMPRIB was stronger than
when using anti-BMP4 antibody. This may be explained
by the fact that BMPRIB is a common receptor used
by several other BMPs in addition to BMP4 (Nilsson &
Skinner 2003, Shimasaki et al. 2004). Nonetheless,
the significant effect induced by BMP4 immunisation
(O80% of effect induced by anti-BMPRIB) indicates
that BMP4 is likely to be the most effective BMP among
other ligands in the process of primordial follicle
formation (Lawson et al. 1999) and recruitment (Tanwar
et al. 2008) in mice and perhaps less so in later stages of
follicular development.
After puberty and irrespective of treatment, the
significantly increased degree of depletion of primordial
and primary follicles with age is expected, possibly due
to increased post-pubertal follicular development and
late cyclic recruitment of mature follicles (Broekmans
et al. 2007). In support of this, the rate of ovulation was
increased with age, therefore indicating that the maturity
of animals increased reproductive activity.
Based on our observations, it is interesting to mention
that the numbers of primordial follicles in treated and
untreated animals continue to decrease with age of mice
(these results) and sheep (Ruoss et al. 2009). However,
the pattern of such reduction appears species-specific.
While in sheep a dramatic decline was observed during
the early stages of life (from birth to 1.5 year, Ruoss et al.
2009), it is only observed in older mice at the age of 16
and 28 weeks. In contrast, the numbers of primordial
follicles in untreated mice remain unchanged up to the
age of 10 weeks. The sustained numbers of primordial
follicles over this relatively long period of mouse life may
support the previous reports demonstrating the existence
of postnatal renewal of primordial follicles in this species
(Johnson et al. 2004, Kerr et al. 2006) and more recently
in human (White et al. 2012).
More interestingly, in treated animals the numbers
of primordial follicles are doubled after immunisation.
Such a significant increase is unlikely due to the
attenuation of primordial follicle depletion alone.
Instead, it appears that in the early-postnatal period
of mice, the role of BMPs is not only limited to the
stimulation of primordial follicle recruitment but also
inhibition of the formation of new primordial germ cells
and primordial follicles, a process which reportedly
exists in this species (Johnson et al. 2004, Kerr et al.
2006). However, a stimulatory action of BMPs on this
process has been reported during mouse foetal develop-
ment (Lawson et al. 1999). Nonetheless, the numbers of
primordial follicles in both treated and untreated animals
declined to the level similar to that in older animals of
different species and postmenopausal women.
While eCG treatment has remarkable effects on
the rate of ovulation as expected, the failure of eCG






















































































Figure 4 Ovulation rates in animals of different treatment groups.
(A) The ovulation rates were estimated in three groups of mice by
manually counting the corpora lutea in every 40th serial section
(200 mm interval) of individual ovaries. In addition to the increase in
ovulation rates with age, the meanGS.D. of ovulation rates were
significantly higher in treated animals with anti-BMPRIB or eCG with
or without antibodies. (B and C) Histological sections showing more
corpora lutea in the ovary of treated animals with anti-BMPRIB (C) than
in control animals (B). *P!0.05; **P!0.01; ***P!0.001;
****P!0.0001. CL, corpus luteum. BarZ100 mm.
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primordial follicles supports the notion that this process
is gonadotrophin-independent (Lee et al. 2001, Orisaka
et al. 2009, Al-Samerria & Almahbobi 2014) and that
there is not a direct action of gonadotrophins on
primordial follicles. In support of this, we have found
that while the expression of BMPRIB was detectable in
follicular cells of mouse primordial follicles, FSHR was
absent but later appeared in primary follicles. These data
together with a previous report in rat (Moore &
Shimasaki 2005) contradict previous reports (Meredith
et al. 1992, Flaws et al. 1997) and therefore suggest the
presence of a complex interplay between gonado-
trophins and other growth factors such as BMPs where
direct and indirect cross-signalling regulates ovarian
function (Tanwar & McFarlane 2011). The reported
decrease in primordial follicles after eCG treatment
(Tanwar et al. 2008) conflicts with the present result
probably due to the manual counting method used in the
previous study instead of the automated stereology used
in this work. The fact that injection of eCG together with
antibody either unexpectedly abolished the effect of
immunisation on primordial and primary follicles or
reduced the immunisation-induced increases in ovu-
lation rates, requiring further investigation. Meanwhile,
we suggest that eCG may act on the larger follicles
whereby its action indirectly antagonises the action of the
antibodies on the small follicles. Together with previous
studies, this study extends our further knowledge
regarding the important role of BMPs but not gonado-
trophins in the recruitment of initial primordial follicle.
Despite the reduction in the rates of transition of
primordial follicles to primary follicles (loss/depletion) in
treated animals, the estimated total numbers and ratios
of primary follicles derived from primordial follicles
in these animals after passive immunisation were
significantly increased rather than decreased. This may
suggest a reduction in apoptosis, allowing more primary
follicles to survive, which requires further investigation.
Also, as BMPs exert a proliferative action on granulosa
cells, promoting early folliculogenesis and oestrogen
production (Guangqin et al. 2013) including the
transformation of primary follicles to further develop-
mental stages, immunisation against BMPRIB will slow
this action hence resulting the accumulation of more
primary follicles.
The novelty of these results may appear inconsistent
with a previous study in rat such as that reported by
Nilsson & Skinner (2003). In rat, the addition of more
BMPs to cultured ovaries stimulated primordial follicle
recruitment, simply monitored by a increased number of
primary follicles therefore decrease number of primor-
dial follicles (Nilsson & Skinner 2003). However, in this
study, the attenuation of BMP action by immunisation
inhibits primordial follicle recruitment monitored by
preservation of these follicles in ovaries when compared
with untreated animals. We believe that the significant
increase in primordial follicle number in treated animals
may also be due to other factors such as stimulation of
de novo formation of primordial follicles. On other hand,
the increase rather than decrease in the numbers of
primary follicles possibly due to inhibition of apoptosis
and the transition of primary follicles to developing
antral follicles.
In this regard, the previously observed reduced
proportion of primary follicles to the total number of
the whole follicle population in the ovaries of anti-
BMP4-treated mice (Tanwar et al. 2008) was probably
due to the significant increase in the numbers of
primordial follicles after immunisation. As in the case
of primordial follicles, the increase in numbers of
primary follicles reduced gradually with age after
reaching its peak at 10 weeks of age.
In contrast to the case of primordial follicles, eCG
treatment alone and in combination with either
treatment significantly reduced the numbers and ratios
of primary follicles. Evidently, this effect reported in this
study cannot be due to a reduced recruitment of
primordial to primary follicles, because eCG has no
effect on the numbers of primordial follicles and
expression of FSHR was not found in primordial follicles.
Instead, it is likely that the reduced numbers and ratios of
primary follicles resulted from the eCG-induced accel-
eration of further development of primary follicles and
transformation to the stages of secondary and preantral
follicles, processes that are promoted by gonadotrophins
(Broekmans et al. 2007, Orisaka et al. 2009). Clearly, the
more the age of animal the more accelerated the follicle
development occurs, and less persistent primary follicles
were found as previously reported in older ewes (Ruoss
et al. 2009). This effect was more obvious in treated
animals probably because of reduced recruitment rates
of primordial to primary follicles.
The significant increase in the ovulation rate in mice
treated with anti-BMPRIB mimics the well-characterised
feature of Booroola sheep (Mulsant et al. 2001, Souza
et al. 2002, Ruoss et al. 2009), which exhibit mutation
in BMPRIB (Wilson et al. 2001, Campbell et al. 2006,
Ruoss et al. 2009). It should be noted that the estimated
total numbers of counted corpora lutea represent
accumulated ovulation of multiple cycles at a given
age. No attempt was made to exclude corpora lutea
that were formed and persisted before the treatment
because this is a comparative study between treated
and untreated animals within each individual age group.
The numbers of corpora lutea formed from cycles before
the time of treatment were equally present and
accounted for in all treated and untreated animals.
The underlying mechanism of BMP action in the
regulation of ovulation is not well understood (McNatty
et al. 2007). However, it has been reported that BMPs
inhibit the gonadotrophin-induced progesterone pro-
duction by maturing follicles (Xia et al. 2003, Pierre et al.
2004, McNatty et al. 2007), in addition to its inhibitory
action on final cell differentiation (Cejalvo et al. 2007),
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in this case granulosa cell luteinisation. In another study,
we have found that protein expression of BMPRIB in
granulosa cells obtained from IVF patients is significantly
downregulated in dominant follicles (Regan et al. 2012).
It appears that the downregulation of BMP signalling
system is a pre-requisite for the late follicle maturation,
granulosa cell differentiation and progesterone for-
mation hence ovulation.
In conclusion, this study demonstrates that the
role of the BMP signalling system is likely to be an
important regulator of ovarian function, particularly the
processes of follicle development, depletion and ovu-
lation. These results, together with our previous studies
in mice (Tanwar et al. 2008), sheep (Ruoss et al. 2009)
and humans (Regan et al. 2012) and other studies in
mice and rats (Lawson et al. 1999, Erickson & Shimasaki
2003, Nilsson & Skinner 2003), confirm that this role of
BMPs in the regulation of ovarian function is applicable
across different species and experimental conditions.
We propose that the attenuation of BMP signalling
system is an effective approach to increase female
fertility reserve while promoting follicle development,
ovulation and eventually the overall fertility.
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5.1 Abstract  
The transition of primordial follicles to primary follicles is a crucial step in controlling female 
oocyte reserve and length of reproductive life. Gonadotropins (follicle stimulating hormone 
(FSH) and luteinizing hormone (LH) are well known to regulate follicle development by 
enhancing the granulosa and theca cells proliferation and steroid production. Recently, 
several reports have indicated that bone morphogenetic proteins (BMPs) play important 
regulatory roles in recruitment of follicles, ovulation rate and initial stages of follicle 
development, which was found to be gonadotropin-independent. The aim of the current 
study is to investigate the mechanism of interaction, between the gonadotropin receptor 
expression and the BMP signalling during follicle development in mice passively immunised 
against BMP receptor 1B (BMPR-1B) and BMP-4.  
The outcomes of the current study showed tightly coordinated mechanisms of action 
between BMP signalling and gonadotropin receptor expression. First, it shows that the role  
of BMPs in follicle development extends beyond the early stages of follicle development, 
confirmed by significantly increased expression of its receptor (BMPR-1B) in mice treated with 
anti-BMPR-1B. This effect of BMPR-1B attenuation was associated with increased expression 
of the gonadotropin receptors (FSHR and LHR). This regulatory interaction between BMPs and 
gonadotropin was found to be independent of BMP-4 (another important member of BMPs 
involved in transition from primordial follicle to primary fol licle). Gonadotropin hormones  
were appeared to have no role in early stages of follicle development (primordial follicle 
stage). The role of equine chorionic gonadotropin eCG in regulating and enhancing the 
gonadotropin action mediated by BMPR-1B was also revealed from this study. The outcomes  
of the current study suggested that the BMP signalling system is not only involved in 
regulating the early stages of follicle development but also involved indirectly in regulating 
the later stages of follicle development by increasing gonadotropin hormones receptor 
expression, which lead to increases the follicular somatic cell sensitivity toward gonadotropin 
hormones. Attenuation of BMPR-1B could be exploited in further studies as an effective tool 





Follicle development is the key process of female productivity and it is responsible of 
producing single mature oocyte ready for fertilization. This process consists of series of 
chronological and well-regulated steps starting from primordial follicle formation  and ending 
in production of single mature follicle ready for fertilization (McGee and Hsueh, 2000). Very 
few primordial follicles from the recruited population reach ovulation, while the vast majority 
die of atresia. In humans, the quality of these follicles determines the length of reproductive 
life and fertility. The follicle development process was thought to be mainly regulated by the 
actions of gonadotropin hormones mainly FSH and LH. However,  recent studies including 
mutated version of FSH receptor in mice were able to demonstrate that the initial stages of 
follicle development to be FSH independent (Siegel et al., 2013), and  found to be regulated 
by intra-ovarian factors (Al-Samerria et al., 2015), such as the BMP (Lee et al., 2001b, Glister 
et al., 2004, Abir et al., 2008). The BMP signalling pathway was reported to be involved 
directly in the initial stage of follicle formation (Lawson et al., 1999, Nilsson and Skinner, 2003, 
Knight and Glister, 2006), primordial follicle recruitment (Lee et al., 2001a, Nilsson and 
Skinner, 2003, Sun et al., 2010), ovarian steroidogenesis (Shimasaki et al., 1999, Hosoya et al., 
2014), follicle cyclic recruitment (McGee and Hsueh, 2000), ovulation (Moore et al., 2004, Al-
Samerria et al., 2015), and follicle atresia (Shimasaki et al., 1999, Araújo et al., 2010). Hence, 
a coordinated inter-network between the gonadotropin hormones and BMP signalling 
systems is appeared to be existed.  Several recent studies have revealed clues to these 
interactions. For instance, BMP-6 was shown to increase the expression of FSH receptors  
(FSHR) in human granulosa cells in vitro (Shi et al., 2010), on the other hand an inhibitory 
action of BMP-2, BMP-4 and BMP-15 on FSHR formation was reported in granulosa cells in 
chicken (Haugen and Johnson, 2010), ewes (Faure et al. 2005) and rats (Otsuka et al., 2001), 
respectively. However, detailed interactions between BMP signalling and gonadotropin 
hormones in the regulation of follicle development are yet to be determined. BMP receptors  
are categorized as of two types (type I and type II), which activate the BMP signalling through 
ligand binding and activating of a cytoplasmic transcription factors. BMPR-1B is the common 
receptor used by several intra-ovarian BMPs such as BMP 2, 4, 7 and 15 (Shimasaki et al., 
2004). BMP-4, a major intra-ovarian BMP, is involved in formation of PGCs (oocytes) 
(Shimasaki et al., 2004, Shimasaki et al., 1999), recruitment of primordial to primary follicles 
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in Booroola sheep (characterised by natural point mutation in the BMPR-1B)  (Ruoss et al., 
2009) and rat (Nilsson and Skinner, 2003), estrogen production and inhibition of progesterone 
secretion and ovulation (Lawson et al., 1999, Shimasaki et al., 1999, Nilsson and Skinner, 2003, 
Ruoss et al., 2009). However, whether the interactions of BMPR-1B and other BMP ligands 
are gonadotropin dependent is not known. Therefore, the present study investigates the 
interaction between BMP signalling (BMPR-1B and BMP-4) and gonadotropin hormones using 
immunofluorescence detection technique and computer-based analysis to quantify the 
receptors expression intensity in 3D images, specifically the localisation of the membrane 
bound receptors of the BMPs, FSH and LH in primary, secondary and Graafian follicle stages 
of mice ovaries. To this end, an in vivo mouse model with attenuated BMP signalling was 
generated using passive immunisation against BMPR-1B and BMP-4 ligand according to 
(Tanwar et al., 2008, Tanwar and McFarlane, 2011, Al-Samerria et al., 2015) with an aim to 





5.3 Materials and methods 
5.3.1 Animal care and passive immunisation 
Female Swiss mice were kept at the Animal House facility, University of New England, 
Armidale, NSW, Australia. All in vivo experimental procedures were carried out with according 
to the Australian code of practice and were approved by the University of New England animal 
ethics committee. Attenuation of BMP signalling was achieved by passive immunisation with 
anti-BMP-4, anti-BMPR-1B and the role of gonadotropin hormones in regulating follicle 
development were demonstrated by injecting the animal with exogenous eCG (Bioniche 
Animal Health, Armidale, NSW, Australia) as previously described in (Tanwar and McFarlane, 
2011, Al-Samerria et al., 2015). Briefly, 3-weeks old female mice were divided into 6 groups 
(N=4); each group received 100 µl of subcutaneous injections of the following treatment. This 
experimental procedure was repeated thrice and a total of 72 animals were used for this 
study. Four mice from each group were killed by CO2 asphyxiation, 24 h after the last injection 
and at the end of the 4th week. The animals were immediately processed to obtain the 
ovaries. One ovary form each animal was snap-frozen in liquid LN2 and stored a -80 ºC for 2 
weeks before being cryosectioned for in situ immunofluorescent localisation and 
quantification of immunofluorescent intensities of the receptors.  
Table 5-1: Animal treatment groups 
 
5.3.2 Antibodies 
The antibodies for BMP-4 and BMPR-1B used in the passive immunisation experiments were 
raised and fully characterized including their cross reactivity and sequences in our laboratory 
as previously described (Tanwar and McFarlane, 2011, Tanwar et al., 2008). The synthetic 
peptides equivalent to the amino acid 88-102 (ISMLYLDEYDKVVLK) for mouse BMP-4 and aa 
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103-117 for mouse BMPR-1B (NKDLHPTLPPLKDRD) (Invitrogen Australia, Mount Waverly, Vic, 
Australia). The antibodies were raised in chickens and purified from egg yolks. Purification of 
antibodies was done using ammonium sulphate and octanoic acid in a combination according 
to McKinney and Parkinson (1987). Binding specificity and absences of cross reactivity of anti-
BMP-4/anti-BMPR-1B antibodies were reconfirmed for this study using ELISA based test 
against random peptides and DELTA-BLAST analysis respectively.  
5.3.3 Immunofluorescent labelling of BMPR-1B, FSH and LH receptors 
The ovaries were snap-frozen in liquid LN2 before being used for in situ immunofluorescent 
localisation and quantification of BMPR-1B, FSH and LH receptors. Whole frozen ovaries were 
partially embedded in OCT and cut into 10 µm sections using a cryostat (Carl Zeiss, Sydney, 
NSW, Australia). Tissue sections  were mounted on to Superfrost slides (HD scientific supplies 
Pty Ltd, Australia) for immunofluorescent procedures as described in (Al-Samerria and 
Almahbobi, 2014). Briefly, fixation was done using 4% paraformaldehyde at 4C for 7 min. 
Antibodies staining were done using polyclonal anti-BMPR-1B (sc-5679), anti-FSHR (sc-7798) 
and anti-LHR (sc-26341) raised in goat at 4C for overnight in humidified chamber. These 
antibodies were obtained from Santa Cruz Biotechnology, Santa Cruz, CA, USA. The negative 
control was prepared by replacing the first antibody with 4 µg/ml of purified goat IgG (02-
6102) (Life Technologies, Mulgrave, Victoria, Australia). After a serial washing, a rabbit anti -
goat antibody conjugated with Alexa-488 fluorochrome (Life Technologies, Mulgrave, 
Victoria, Australia) used in 4 µg/ml concertation for 45 min at room temperature in dark and 
humidified chamber. All sections were mounted using an anti-fade aqueous mounting 
medium containing 40, 60-diamidino-2-phenylindole (DAPI; Molecular Probes, NSW, 
Australia). Sections were analysed using inverted confocal microscopy (AR1+/A1+; Nikon 
Corporation, Tokyo, Japan). Images were captured using A1+ software (Nikon Corporation, 
Tokyo, Japan). 
5.3.4 Image analysis and Quantification of Immunofluorescent Intensities of the receptors 
Quantification of immunofluorescent intensities of the receptors were done in the granulosa 
cells of the Graafian follicles by placing three (9x103) µm3 sections in three different locations 
of the follicle and the mean of intensities at the regions of interest (ROI) were used in the 
calculation (Figure 2A). The same principle was applied for secondary follicles with a (1x103) 
µm3 sections (Figure 2B) and primary follicle with 250 µm3 in two locations of the follicles 
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(Figure 2C). The comparison performed between different treatments of the follicles in the 
same stages and not between follicles across various stages. Images were captured and 
calculation of intensities of fluorescent signals in different stages of follicle development was 
performed as described by Al-Samerria and Almahbobi, (2014). In brief, the exposure time 
was adjusted using rabbit non-immune serum instead of the 1st antibody, the fluorescent 
single generated was taken as the base to subtract the signals generated by auto-fluorescence 
and non-specific binding. A surplus of fluorescent signal generated after subtraction was 
considered as a positive signal and used in the quantification analyses. For generation of 3D 
images, 10 µm thick physical sections were scanned and Z-stalks of 10 × 1 µm optical 
frames/sections were generated. These Z-stalks were compiled in order to generate the 3D 
images, which were used for quantification of intensity of the immunofluorescent signals 
from the whole 10 µm tissue section using Volocity 3D image analysis software, version 6.2 
(Perkin Elmer; Waltham, MA, USA).  
5.3.5 Statistical analysis 
Immunofluorescent expression intensities at the three different stages of follicle 
development (primary, secondary and Graafian follicles) between the treated and untreated 
animal were analysed using one- a  ANOVA follo ed  Tuke ’s post ho  test for ultiple 
comparisons. The data are presented using Prism version 6 (Graph Pad Software, La Jolla, CA, 
USA) as means ± standard deviations. The differences were considered significant at P<0.05.  
5.4 Results 
5.4.1 Immunofluorescent localisation of receptors in ovarian follicle 
In untreated control animals, there was no fluorescence signal observed in the negative 
control samples incubated with non-immune serum instead of the 1st antibody (Figure 1A, 
B). The positive immuno-labelling localisation of BMPR-1B, FSHR and LHR was demonstrated 
in all stages of follicle development including Graafian follicles (Figure 1).  
While FSHR was observed only in granulosa cells (Figure 1D, H), the expression of BMPR-1B 
and LHR was observed in both granulosa and theca cells in all samples regardless of the 
treatment (Figures 1C, 1E, 1F and 1G). After treatment with anti-BMPR-1B antibody, stronger 
signals of BMPRIB (Figure 1G) or FSHR (Figure 1H) were observed.  
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5.4.2 In situ quantification of BMPR-1B, FSHR, and LHR in three different stages of follicle 
development  
Quantitative analysis, based on the intensity of the fluorescent signals from the 
representative 3D images, of BMPR-1B, FSHR, and LHR expression was conducted in animals 
passively immunised against BMPR-1B, BMP-4 with or without eCG in three stages of follicle 
development (Graafian follicle, Figure 3; secondary follicle, Figure 4 and primary follicles, 
Figure 5). All these analyses were carried out on the signals collected from granulosa cells 
only. The selection of the follicle development stages were done according to Pedersen & 
Peters’ 97  lassifi atio  s he e (Pedersen and Peters, 1971). In Graafian follicles, the 
expression of BMPR-1B, FSHR and LHR showed significant increases after treatment with anti-
BMPR-1B antibody with or without eCG (Figure 3A-C). Treatment with eCG alone also caused 
significant increases in the expression of BMPR-1B and FSHR (Figure 3A, B, respectively) but 
not in LHR (Figure 3C). In contrast, immunisation with BMP-4 antibody alone or with eCG 
administration did not show any significant change in the expression of either receptor, when 
compared to the level of expression in control animals (Figures 3A-C). In secondary follicles, 
expression of BMPR-1B, FSHR and LHR was significantly increased after treatment with anti -
BMPR-1B alone (Figure 4A-C). Treatment with anti-BMPR-1B plus eCG induced significant 
increase in the expression of BMPR-1B only but not FSHR or LHR. None of other treatments 
caused any significant change in either receptor. In primary follicles, only the treatment with 
anti-BMPR-1B with or without eCG induced significant increase in the expression of BMPR-1B 
only (Figure 5A-C). Regardless of the treatments, the LHR expression was completely lacking 




5.5 Discussion  
The present study was designed to investigate the mechanism of interaction between the 
gonadotropin hormones and the BMP signalling during follicle development in mice. The 
study was implemented by using passive immunisation of selective BMPR and ligands. The 
localisation of the receptors was visualized by in situ immunofluorescent staining followed by 
computer-based quantitative analysis. It should be kept in mind that this kind of 
immunofluorescence technique is not efficient enough to detect the small changes of 
immunofluorescent signals. Moreover, they represent only the signals that are reflected from 
the surface of sections and thus do not represent the amount of molecules in the tissue 
structure. However, using the 3D image quantification analysis enabled us to measure the 
fluorescent signals generated by immunofluorescent labelling and correlated with the 
receptor protein expression, hence, the expression level of the receptors can be interpreted 
indirectly in terms of the intensities. This method has already provided a promising result (Al-
Samerria and Almahbobi, 2014), hence used in the present study. 
The two gonadotropic hormones, (FSH) and (LH), believed to play primary roles in controlling 
ovarian function and in particular the early stage of follicle development (Flaws et al., 1997). 
However,  we have demonstrated a positive expression of BMPR-1B and lack of expression of 
FSHR in the follicular somatic cells of primordial follicles in sheep (Al-Samerria and Almahbobi, 
2014) and mice (Al-Samerria et al., 2015). This observation suggested that early stage of 
follicle development was mainly regulated by the action of BMP signalling not the 
gonadotropins. These observations supported by other reports suggested that initial stages 
of follicle recruitment being gonadotropin-independent (Jaatinen et al., 1996). Furthermore, 
the involvement of intra-ovarian factors, such as BMPs, in this process has directed us to 
investigate the actual coordinated mechanism involved between the gonadotropin hormones  
and the BMP signalling (Tanwar et al., 2008, Ruoss et al., 2009).  
In the present study, the changes in the protein expression of the BMPR-1B, FSHR and LHR in 
the follicular somatic cells (granulosa and theca cells) induced by passive immunisation in 
mice against BMPR-1B and BMP-4 demonstrated the tightly coordinated mechanisms of 
action between BMP signalling and the gonadotropin hormones. The Increased ovulation was 
shown to be due to BMPR-1B natural attenuation in Booroola sheep and passively immunised 
mice (Ruoss et al., 2009, Al-Samerria et al., 2015). Even, indirect up-regulation of BMPR-1B by 
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FSHR was demonstrated previously (Al-Samerria and Almahbobi, 2014). Extending to these 
observations, the present study showed that later stages of follicle development (in 
secondary follicles and Graafian follicles) are also regulated by BMPR-1B indirectly by 
i reasi g the re eptors’ expression (increase the number of the receptors) and ultimately 
leading to increased sensitivity of the follicular somatic cells toward gonadotropin hormones. 
Similar increased in the follicular somatic cell sensitivity towards gonadotropin has also been 
linked with enhanced cellular proliferation (Findlay and Drummond, 1999), reduced apoptotic 
activity (Zhang et al., 2013), luteinisation and increased steroidogenic activity (androgen, 
oestrogen and progesterone production) (Miyoshi et al., 2006, Wang and Roy, 2009). The 
significant increase of the BMPR-1B expression in mice vaccinated against BMPR-1B 
with/without eCG could be due to the observed up-regulation of FSHR and LHR, which was 
supported by similar pattern of up-regulation in the expression of FSHR and LHR which caused 
due to point mutation in BMPR-1B in Booroola sheep (Regan et al., 2015). The localisation of 
BMPR-1B and LHR in both the granulosa and theca cells compared to the exclusive localisation 
of FSHR in the granulosa cells in the Graafian follicle of mice vaccinated against BMPR-1B 
indicated wider spectrum of action of BMPR-1B and LHR than that of FSHR. Further studies 
can dissect the reason of specific localisations of these receptors with regard to their function 
in later stages of follicle development. 
The up-regulation of BMPR-1B, FSHR and LHR due to attenuation of BMPR-1B was 
demonstrated in the secondary follicles similar to that of Graafian follicles.  The up-regulation 
of BMPR-1B expression could be due to the auto-compensation effect to overcome the 
inhibitory action of the vaccination. Up-regulation of BMPR-1B expression in granulosa cells 
of secondary follicles indicated that BMPs role in follicle development is also extended beyond 
the early stages of the follicle development. It was also supported by the observations of BMP 
signalling being essential for granulosa cells including cell proliferation and differentiation 
(Shimasaki et al., 2004) as well as for the oocyte-granulosa cells communication (Otsuka et 
al., 2001, Yi et al., 2001).  This observation implied that follicle development process is tightly 
controlled by the BMPs action directly by regulation at the early stages for follicle 
development and indirectly by enhancing the granulosa cells sensitivity by up-regulation of 
gonadotropin action (FSHR and LHR) leading to enhanced steroidogenic activity (oestrogen 
and progesterone productions) (Nilsson and Skinner, 2003, Shimasaki et al., 2004, Khalaf et 
al., 2013, Hosoya et al., 2014). Selective up-regulation of BMPR-1B and FSHR in the Graafian 
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follicles treated with eCG indicated that eCG could stimulate FSH production, which was also 
supported by the observation of production of FSH ligand by eCG (Murphy, 2012). FSH ligand 
could up-regulate FSHR (Findlay and Drummond, 1999), and thus, eCG could indirectly up-
regulate BMPR-1B expression in the present study. This observation showed the role of eCG 
in regulating and enhancing the gonadotropin action mediated by BMPR-1B. 
Previously we have demonstrated that attenuation of BMP-4 using passive immunisation 
increases the total number of primordial and primary follicles in mice (Al-Samerria et al., 
2015). This observation indicated that the passive immunisation was effective. However, the 
attenuation of BMP-4 with/without eCG showed no effects on BMPR-1B, FSHR and LHR 
protein expression. This observation suggested that the interaction between BMPs and 
gonadotropin is independent of BMP-4, possibly occurring at an intracellular level. It is 
important to note that the outcome of the current study does not contradict the known fact 
of BMP-4 being essential for follicle development as reported earlier (Nilsson and Skinner, 
2003), but rather restricts its role to be not effective in regulating BMPR-1B, FSHR and LHR 
expression. BMP-4 was shown to play an important role during the transition from primordial 
follicles to primary follicles (Tanwar et al., 2008, Al-Samerria et al., 2015), however, whether 
its involvement is regulated by SMAD signalling or cAMP pathway requires further studies. 
The unaffected or little reduced expression of the FSHR in all the 3 follicle stages in BMP-4 
attenuated mice could be explained by the fact that BMP-4 is known to inhibit epidermal 
growth factor (Chen et al., 2013), which was again known to down regulate FSHR expression 
(Findlay and Drummond, 1999). Hence passive immunisation with anti-BMP-4 could thus 
reduce FSHR expression indirectly through up-regulation of epidermal growth factor (EGF). 
The attenuation of BMP-4 showed no effects on BMPR-1B, FSHR and LHR expressions in 
secondary follicle. This observation suggested that the interaction between gonadotropin 
hormones and BMPs occurred at the level of receptors (intracellular level) not at the level of 
the ligands (extracellular), however further investigation is required to understand this. 
Attenuation of BMPR-1B in the primary follicles resulted in up-regulation of BMPR-1B and had 
no effects on the FSHR expression. This observation suggested that BMPR-1B expression was 
pre-requisite for the onset of the follicle development in early stages of follicle development. 
It could include the stages of PGCs formation, and the transition of the primordial to primary 
follicles as BMPR-1B was shown to be expressed in granulosa cells  of the primordial follicles 
and no FSHR or LHR expression were detected in sheep (Al-Samerria and Almahbobi, 2014) 
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and mice (Al-Samerria et al., 2015). No significant effect on the FSHR and lack of LHR 
expression in the primary follicles in the present study reconfirmed that gonadotropins (FSHR 
and LHR) have no direct effects at the early stages of follicle development (Campbell et al., 
2009). It was supported by the findings of Campbell et al (2009) that the increase in prolificacy 
in Booroola sheep (with natural point mutation in the BMPR-1B) was not because of the 
i rease i  F“H le el, ut as due to i rease i  gra ulosa ells’ se siti it  ediated by other 
intra-ovarian factors such as BMPs. In the present study, up-regulation of BMPR-1B, FSHR and 
LHR expression in the secondary and Graafian follicles with anti-BMPR-1B with and without 
eCG could be explained by an auto compensation phenomenon to overcome the inhibitory 
action of the vaccination. This type of unequivocal interaction between BMPR-1B and the 
gonadotropin hormones in vivo for follicle development has not be shown so far, and can 
open new roads to study and enhance the reproductive life in female mice and ultimately in 
humans. 
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5.8 Figures & Figure Legends  
 
Figure 5-1: The expression of BMPR-1B, FSHR and LHR using immunofluorescence localisation in 
Graafian follicles. 
A: negative control with DAPI staining (red staining). B: negative control of 10 µm 3D Z-stack. C: BMPR-
1B in granulosa and theca cells (green staining). D: FSHR in granulosa cells only. E: BMPR-1B in theca 
and granulosa cells in animals immunised with anti-BMPR-1B. F: BMPR-1B in theca and granulosa cells 
in animals immunised with anti-BMPR-1B plus eCG. G: LHR in theca and granulosa cells in animals 
immunised with anti-BMPR-1B. H: FSHR in granulosa cells in animals immunised with anti-BMPR-1B. 





Figure 5-2: Immunofluorescence quantification. 
A: Graafian follicle, a cubic have been placed in three different locations on granulosa cells (10 µm 
height x30 µm width x 30 µm length) µm3, Scale Bar=50 µm. B: Secondary Follicle, a cubic have been 
placed in three different locations on granulosa cells (10 µm height x 10 µm width x 10 µm length) 
µm3, Scale Bar=10 µm. C: Primary Follicle, a Cubic have been placed in two different locations on 






Figure 5-3: In situ quantification of the expression of receptors (pixel/μm2) in Graafian follicles 






Figure 5-4: In situ quantification of the expression of receptors (pixel/μm2) in Secondary follicles 






Figure 5-5: In situ quantification of the expression of receptors (pixel/μm2) in Primary follicles after 
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6.1 Abstract  
The bone morphogenetic proteins (BMP) were recently shown to have various important 
roles in the initial stages of folliculogenesis, which include recruitment of primordial follicles, 
transition of primordial follicles to primary follicles and increase ovulation rate. Although 
gonadotropins including follicle stimulating hormone (FSH) and luteinizing hormone (LH) are 
known to regulate folliculogenesis, recent studies have shown that the early stages of 
folliculogenesis to be gonadotropin-independent. We have recently demonstrated that 
modulation of BMP signalling system influences ovarian FSHR and LHR expression. This 
observation suggested the existence of the interaction between BMP signalling and 
gonadotropin at the cellular receptor level. The aim of the present study is to investigate if 
the interaction between BMP receptors signalling systems and gonadotropin (FSHR and LHR) 
expression is evident at the nuclear or transcript level. The results of this study showed a 
significant increase in mRNA of both FSHR and LHR in mice treated with anti-BMPR-1B, and 
thus the effect at the transcript level were confirmed. The involvement of gonadotropin 
hormones for the induction of FSHR and LHR expression for overall follicle development by 
administration of equine chorionic gonadotropin eCG at the transcript level was also 
confirmed. Further, the results confirmed that passive immunisation of BMP signalling can be 






The BMPs are highly conserved members of the transforming growth factor-  superfamily. 
Among their diverse morphogenetic roles, they are well known for their critical roles in 
multiple aspects of embryogenesis (Hogan, 1996). Mammalian reproduction is controlled by 
coordinated and episodic release of gonadotropin releasing hormones and subsequent 
secretion of the pituitary gonadotropin. Gonadotropins namely the folliclestimulating 
hormone (FSH) and the luteinizing hormone (LH) are involved in oocyte development, cyclic 
follicles recruitment and development which is considered as central to female reproduction. 
Female folliculogenesis progresses through systematically regulated and coordinated 
processes involving primordial follicle development and recruitment, follicle development, 
maturation and, finally, production of single mature oocyte required for fertilization (Knight& 
Glister 2006). This process of production of mature oocyte is tightly regulated and influenced 
by several intra-ovarian factors and hormones, since it starts from a population of primordial 
follicles and ends up with only one mature oocyte. Further, the folliculogenesis process is also 
responsible for the length of the reproductive life, fertility and the menopause in women. 
Among the other intra-ovarian factors, the BMP system is known to play a key role in the 
regulation of gonadotropin regulated folliculogenesis as well as mitosis  in granulosa cells 
(Otsuka, et al., 2011). Recent studies conducted in our laboratory and others have 
demonstrated the role of BMPs in several stages of folliculogenesis such as ovarian 
steroidogenesis (Shimasaki et al., 1999, Hosoya et al., 2014), cyclic follicle recruitment 
(McGee and Hsueh, 2000), formation of the primordial germ cells (Lawson et al., 1999, Nilsson 
and Skinner, 2003, Knight and Glister, 2006), recruitment of primordial follicles (Lee et al., 
2001a, Nilsson and Skinner, 2003, Sun et al., 2010), regulating ovulation rate (Moore et al., 
2004, Al-Samerria et al., 2015) and follicle atresia (Shimasaki et al., 1999, Araújo et al., 2010). 
Several BMP members, such as BMP-6, BMP-7, and BMP-15 have recently been shown to be 
directly involved in regulation of gonadotropin function such as prevention of immature 
ovulation (McNatty, et al 2009), FSH receptor signalling   (Huang, et al 2001), FSH synthesis 
and secretion (Otsuka et al 2002) and initial follicle recruitment (Ruoss et a l 2009). For 
instance, BMP-6 is suggested to be involved in regulating the increase of FSH receptor 
expression (FSHR) in human granulosa cells in vitro (Shi et al., 2010). Further, FSHR synthesis 
in the pituitary gland was shown to be inhibited by the action of BMP-2, BMP-4 and BMP-15 
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in chicken granulosa cells in vitro (Haugen and Johnson, 2010) and ewe (Faure, et al., 2005) 
and rat granulosa cells (Otsuka et al., 2001). on the other hand, BMP-4 was shown to control 
follicle longevity and primordial follicle development (Nilsson and d Skinner, 2003). Recent 
studies conducted in our laboratory have found that the initial stages of follicle recruitment 
are gonadotropins independent and rather BMPs dependent (Lee, et al. 2001, Knight & 
Glister, 2003, Abir, et al. 2008). All these recent studies have led to the suggestion that BMP 
signalling regulate different stages of folliculogenesis by controlling gonadotropin sensitivity 
and secretion from pituitary gonadotropins (Takeda, et al 2011). 
BMP signalling   is transduced through a heterodimeric complex consisting of type I and type 
II receptors (BMPR-1 and BMPR-2), which are transmembrane serine/threonine kinase 
receptors (Yamashita et al 1996). The BMP receptors transduce the BMP functions by binding 
with various ligands and activating various transcription factors. BMPR-1B was shown as the 
common receptor of several other BMPs such as BMP 2, 4, 7 and 15 (Shimasaki et al., 2004). 
Therefore, it has been selected to conduct this study. To this end, the present study was 
designed to analyze the expression level of FSH and LH receptors  at transcript level, in vivo, 
in mice ovarian follicle cells, in response to BMP system attenuation (BMPR-1B and BMP-4) 
and gonadotropin administration. BMPs attenuation was gained through applying passive 
immunisation against BMP receptor and ligand, and gonadotropin stimulation by eCG 
administration as described in our previous studies. The expression was investigated at the 
transcript level by using quantitative real time qPCR. The study aims to understand the 




6.3 Materials and methods 
6.3.1 Passive immunisation a d experi e tal a i als’ growth co ditio  
For passive immunisation, 16 female mice were grown in controlled conditions in the 
Physiology Animal House facility, University of New England, Armidale, NSW, Australia for the 
entire experimental period (till four weeks). The in vivo experimental procedures conducted 
in this study were approved by the University of New England Animal Ethics Committee. The 
experiments adhered to an Australian code of practice. Passive immunisation against (BMPR-
1B and BMP-4) was done to attenuate BMP signalling system. And eCG was administered to 
the animals for gonadotropin stimulation. For this purpose, anti-BMP-4, anti-BMPR-1B and 
eCG (eCG; Bioniche Animal Health, Armidale, NSW, Australia) were used according to Tanwar 
and McFarlane (2011) and Al-Samerria et al. (2015). Three-week old female mice were divided 
into four groups of four each (N=4) and were given 100 µl of antibodies subcutaneously for 7 
days as outlined in further details in Table 1. 
Table 6-1: Animal groups and treatment 
 
Mice were killed by CO2 asphyxiation after 24 h of the last injection and immediately 
processed for recovery of the ovarian samples. This experimental procedure was repeated 
thrice and a total of 48 animals were used for this study. Sample ovaries were preserved in 




6.3.2 Antibody preparation 
Antibodies used in this study for passive immunisation were raised against BMP-4 and BMPR-
1B in chicken, purified from egg yolks and injected subcutaneously as 50 µg in 100 µl saline as 
described in (Tanwar and McFarlane, 2011). The doses of the antibodies were determined in 
the pilot studies. Briefly, the synthetic peptides equivalent to amino acids 88-102 
(ISMLYLDEYDKVVLK) for mouse BMP-4 and amino acids 103-117 for mouse BMPR-1B 
(NKDLHPTLPPLKDRD) (Invitrogen Australia, Mount Waverly, Vic, Australia) were used. These 
antibodies were generated and fully characterized previously in our laboratory (Tanwar and 
McFarlane, 2011, Tanwar et al., 2008) for their specificity and cross-reactivity using ELISA test 
and DELTA-BLAST analysis. Antibody purification was accomplished using ammonium 
sulphate and octanoic acid in a combination (McKinney and Parkinson 1987). The synthetic 
peptides were conjugated to diphtheria toxoid (CSL) and emulsified in Freunds complete 
adjuvant (Sigma-Aldrich Pvt Ltd) for primary vaccination and with Freunds incomplete 
adjuvant for booster injections. 
6.3.3 RNA extraction and RT-PCR 
The RNA extraction and reverse transcription of RNA were carried out by following the 
methodology adapted from Ciller et al., 2016. Briefly, fresh mouse ovaries were collected and 
stored in RNA Later Ⓡ solution (Ambion, Austin, TX, USA) at 4 °C overnight according to the 
a ufa turer’s instructions. Left-side ovaries were used for total RNA extraction using TRI 
reage t as per a ufa turer’s i stru tio s T94 4: “ig a-Aldrich Pty Ltd, Castle Hill, NSW, 
Australia). RNA purity was determined using Nano-Drop 8000 (Thermo Fisher Scientific, Inc, 
Wilmington - USA) and RNA integrity was checked using 1% agarose gel electrophoresis (Le 
Bourhis et al., 2005). Isolated total RNA was stored at - 80C until use. 2 µg of total RNA was 
reverse transcribed to cDNA using Oligo (dT) 15 Primer and M-MLV Reverse Transcriptase 
(Promega, Alexandria NSW) and in the presence of rRNasinⓇ RNase Inhibitor (Promega, 




6.3.4 Primers and qPCR 
The reference Beta actin β-actin) gene primers sequences were as described in Ciller et al., 
2016 and the rest of primers used in this study  (FSHR, LHR, SDHA and 18s) were designed in-
house using NCBI-Primer blast software (Ye et al., 2012) and were synthesized in Gene Works 
Australia (Thebarton, South Australia SA, 5031, Australia). The primers used and their 
sequences are presented in Table 2. The specificity of the primers was confirmed by following 
the methodology described by Ciller et al., 2016. The polymerase chain reactions (PCR) were 
carried out using a BioRad CFX384 TouchTM Real-Time PCR Detection System using Fast 
EvaGreen qPCR Mix (Biotium, Hayward CA). For qPCR reaction, a 16-80 ng of control ovary 
cDNA was used. The qPCR was carried out using 2X Fast Plus Green qPCR mix, 16 ng of cDNA, 
primers of 1 mM final concentration in triplicates using β-actin, SDHA and 18s as reference 
genes in total volume of 1 µl. 
Table 6-2: Primers used in this study 
 
6.3.5 Statistical analysis 
The total number of mice was 16 for one set of experiment (N=16). For quantifying the relative 
changes in the gene expression in the samples were estimated using the 2-ΔCT method adapted 
from Livak et al (2001). Relative PCR amplification of the target genes were calculated after 
normalization with the geometric mean of the three reference genes as described by 
Vandesompele et al., 2002 (Vandesompele et al., 2002). Differences in the expression level 
between the treated and untreated animal, in whole ovaries were analysed using one-way 
analysis of variance (ANOVA) followed by a Student–Newman–Keuls multiple range test and 
using the SAS computer software package (SAS Institute Inc., Cary, NC, USA). The differences 




6.4.1 Relative expression of transcripts of FSHR and LHR after different treatments 
Quantification analysis based on relative levels of transcript expression was carried out to 
investigate the FSHR and LHR expressions in the whole ovaries of mice immunised against 
anti-BMPR-1B, anti-BMP-4 and administrated with eCG for gonadotropin stimulation. All 
results for the whole ovaries. RT-PCR quantification showed similar profiles (Figure 6.1) of 
gene expression for FSHR and LHR in ovarian homogenates with a significant increase in FSHR 
and LHR expression in mice treated with anti-BMPR-1B or administrated with eCG, when 
compared against untreated control animals. Treatment with anti-BMP-4 showed no 
significant changes of FSHR and LHR mRNA when compared to the untreated control animals. 
Treatment with eCG showed the highest increase in the FSHR and LHR mRNA expression levels 
(Figure 6.1).  
6.5 Discussion 
The present study was designed to identify whether the interaction between the 
gonadotropin and the BMPs occurs at the transcript level. The study was accomplished by 
investigating the gonadotropins receptor expression (mRNA) in mice passively immunised 
against BMPR-1B and BMP-4 respectively to attain transient attenuation of the BMP signalling 
system. The interaction was analysed at the transcript level by comparing the relative 
expression of mRNA levels after reverse transcription and quantification of cDNA by Real-time 
PCR. Basically the ovarian cells immunised with BMPR-1B, BMP-4 or administrated with eCG 
were compared for transcripts of FSHR and LHR in mice ovaries. Although whole ovaries were 
taken for experimental analysis, the results most properly represent changes in the granulosa 
and the theca cells. Since FSHR expression and LHR are restricted in these two tissue cells. 
Hence the granulosa and the theca cells were indirectly targeted for the interaction study by 
studying expression of FSHR and LHR. The two gonadotropins FSH and LH are the central 
players in female reproductive function including most of the ovarian function and ovarian 
folliculogenesis. However, recently it was found that FSH mutant version of mice could retain 
folliculogenesis (Siegel et al. 2013). Further, positive expression of BMPR-1B and lack of 
expression of FSHR in the primordial follicles in sheep and mice (Al-Samerria and Almahbobi, 
2014; Al-Samerria et al., 2015) confirmed that the early stage of follicle development was 
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primarily regulated by BMP signalling system. Enhanced expression of the FSHR and LHR due 
to a point mutation in BMPR-1B (Reagan, et al., 2015) and the observations of indirect up-
regulations of BMPR-1B by FSHR (Al-Samerria and Almahbobi, 2014) in the previous studies 
indicated a definite interaction of BMPR-1B and the gonadotropin receptors which is reflected 
in the protein level expression of the receptors. In addition to BMPR-1B, BMP-4 is also 
included in the study since BMP-4 is a dominant intra-ovarian BMP involved primary follicle 
transition, recruitment and formation of primordial germ cells (Shimasaki et al., 2004, 
Shimasaki et al., 1999); (Ruoss et al., 2009). Immunisation specific for BMPR-1B resulted in 
significant increase in the FSHR and LHR transcript levels, which was not observed in case of 
immunisation with anti-BMP4. This observation was also supported by the weak protein level 
expression of gonadotropin receptors when using anti-BMP4 compared to anti-BMPR-1B (Al-
Samerria et al 2015). The experiments were designed in whole ovaries, thus includes an 
overall analysis during all stages, irrespective of any specific stage of follicle development.  
The administration of eCG also resulted in significant increase in the FSHR and LHR transcript 
levels indicating that the role of gonadotropin in overall follicle development being significant 
at transcript level. However, early stages of folliculogenesis were previously found to be 
gonadotropin-independent, albeit at protein level (Orisaka et al. 2009). Further studies can 
be conducted to ascertain the involvement of FSHR and LHR at transcript levels in the early 
stages of follicle development in animals administrated with eCG, which could reveal whether 
the non-dependence of early stages of folliculogenesis from gonadotropin is at transcript 
level. Thus, the present study extended the knowledge of interaction of BMP receptors with 
the gonadotropin receptors to transcript level. The interaction appears to occur at the nuclear 
level, thus the transcription of the gonadotropin receptors is influenced by the absence of the 
BMP receptors. This level of interaction is novel, and it would be interesting to investigate the 
factors and regulators of this interaction between the BMP receptors and the gonadotropin 
receptors. In addition, it would be useful to confirm the changes in BMP signalling by 
examining the anticipated downstream effects in the signalling pathway including 
examination of phosphor-Smad 1/5/8 in follicles.  
In conclusion the current study reconfirms that attenuation of BMP signalling through passive 
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6.8 Figure and figure legends  
 
Figure 6-1: Relative gene expression (mRNA) levels of FSH and LH receptors in whole ovaries after 
different treatments.  The difference was considered significant at (P < 0.05)  
A: The FSHR mRNA (ΔCT value) level obtained by qPCR; B: The LHR mRNA (ΔCT value) level obtained by 
qPCR. B: The LHR mRNA (ΔCT value) level obtained by qPCR; B: The LHR mRNA (ΔCT value) level 





Chapter 7 : General discussion  
This chapter gives an overview of the four studies undertaken to understand the role of BMP 
signalling in follicle development, primordial follicle consumption, primordial to primary 
follicle transition, primary follicle survival, ovulation rate, their receptor expression patterns  
at the protein and transcript level and also their interaction with the gonadotropins. The 
complex nature of ovarian structure and the process of folliculogenesis through different 
stages were a main focus of the study. Previously, the role of BMP signalling in follicle 
development was studied either through the natural (i.e., in vivo) mutation in BMP receptor 
(Ruoss et al., 2009), in gene knockout model (Zhang and Bradley, 1996), in an in vitro method, 
accessed at molecular or biochemical level (Wang and Roy, 2009) or in an in situ method 
assessed manually through subjective methods of microscopy (Erickson and Shimasaki, 2003).  
The first aim of my studies was to determine the temporal-spatial expression of the BMP 
receptors and the gonadotropin hormone receptors (FSHR and LHR) in sheep, during the 
various stages of follicle development in situ by using the non-biased computerized 3D-image 
analysis system. The results of this study showed for the first time the utility of 
immunofluorescence labelling combined with computer based intensity quantification using 
3D-image analysis, compared to previous methods. The approach enabled more precise 
quantification and gave statistically significant findings which would not have been possible 
with the previous manual methods, where measurement is more subjective and based on 
scoring (between 0 and 4 for no staining to intensive staining) (Ilanthodi, 2012). Further, the 
3D-image analysis reconfirmed the specific expression of the gonadotropin and BMP 
receptors to follicular somatic cells (granulosa and theca cells) during different stages of 
follicle development i.e. primordial, primary, secondary and Graafian, which opened new 
facets of involvement of BMP signalling in the follicle development. The lack of gonadotropin 
receptor expression in primordial follicles suggested that the early stage of follicle 
development is gonadotropin-independent. The outcome of this study clarifies the ambiguity 
of the involvement of gonadotropin in primordial follicle development (Flaws et al., 1997, 
Meredith et al., 1992).  
The longevity of female fertility is highly dependent on the number and quality of primordial 
follicles, the repetitive process of ovulation after puberty and continuous process of follicle 
atresia leading to the depletion of fertility reserve (Williams and Erickson, 2008). Hence, as a 
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part of the present study and the second aim of this thesis the role of BMP signalling in 
primordial follicle formation, primordial follicle recruitment, the primary follicle survival and 
ovulation were investigated using an in vivo mouse model.  Attenuation of BMPR-1B and 
BMP-4 action was achieved by passive immunisation, and the effects were examined in the 
presence or absence of eCG, as a source of exogenous gonadotropin. The estimated number 
of primordial and primary follicles was counted using computer based stereological technique 
(Chapter 4). The results of this particular study showed that the effect of immunisation on 
primordial follicle reserve and ovulation rate was stronger in case of BMPR-1B than that of 
BMP-4 immunisation/attenuation, suggesting a lesser role for BMP-4 than BMPR-1B, in 
primordial follicle formation (Lawson et al., 1999) and recruitment (Tanwar et al., 2008). The 
passive immunised mouse model worked as a transient elicitor model. However, the effect of 
immunisation against BMP system showed an extended effect for several weeks after 
immunisation, which is unlikely due to the direct inhibitory action of antibodies. The increase 
in ovulation rate in vaccinated mice mimics the well-characterised feature of Booroola sheep 
(Mulsant et al., 2001, Souza et al., 2002, Ruoss et al., 2009), which exhibit mutation in BMPR-
IB (Wilson et al., 2001, Campbell et al., 2009). Together with the other results in mice, sheep, 
and human, this study confirmed that attenuation in BMP signalling can be an effective 
approach to increase female fertility reserve by promoting follicle development and 
ovulation. As discussed later, eCG also had an influence on BMPR-1B expression.  
With this result, the next aim was to investigate the mechanism of interaction between the 
gonadotropins and the BMP signalling during various stages of follicle development and 
constitutes the third aim of the thesis. The method adopted for this study was in situ 
immunological visualization with immunofluorescence quantification. The effect of passive 
immunisation of BMPR-1B, a common a receptor for BMP-4, on BMPR-1B, FSHR and LH 
expression was demonstrated in different stages of follicle development. Significant increase 
in BMPR-1B, FSHR and LHR expression was observed in mice vaccinated against BMPR-1B with 
and without eCG administration.  
The results of the current study suggested coordination between the actions of BMP and 
gonadotropin consistent with previous reports (Miyoshi et al., 2006, Chen et al., 2013). In 
addition to BMPR-1B controlling the initial stages of primordial follicle recruitment, this study 
suggested an indirect role of BMPR-1B in the later stages of folliculogenesis, such as 
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secondary and Graafian follicles, as evidenced by increased FSH and LH receptor expression, 
which lead to increased follicular somatic cell sensitivity towards gonadotropins. The study 
also revealed a wider spectrum of expression of BMPR-1B and LHR as compared to FSHR due 
to the observed localisation of BMPR-1B and LHR in both granulosa and theca cells, whereas 
FSHR expression was restricted to granulosa cells. These results have suggested that the 
action of BMPs extends beyond the early stages of follicle development. Hence, the follicle 
development was shown to be regulated by direct actions of BMP in early stages of 
development as well as by indirect actions through increased sensitivity of the granulosa cells 
and up-regulation of gonadotropin receptors. The increases in the follicular somatic cells 
sensitivity towards gonadotropin enhances cellular proliferation (Findlay and Drummond, 
1999), reduce apoptotic activity (Zhang et al., 2013), luteinisation and increases in the 
steroidogenic activity (androgen, oestrogen and progesterone production)(Miyoshi et al., 
2006, Wang and Roy, 2009), which ultimately  leads to improve the reproductive capacity.  
Interestingly, the granulosa cells of mice treated with eCG administration showed an increase 
in BMPR-1B and FSHR but not LHR expression. This observation suggested that the role of eCG 
in regulating and enhancing the gonadotropin  could involve BMPs. This observation 
suggested that the role of eCG in regulating and enhancing the gonadotropin action via their 
receptors are mediated by BMPs.  
The attenuation of BMP-4 through vaccination, either in the presence or absence of 
administered eCG, had little effects on BMPR-1B, FSHR and LHR protein expression. This 
observation suggested that the interaction between BMPs and gonadotropin occurred at an 
intra-cellular level (e.g. through regulating SMAD or cAMP). This observation  also provides  
further confirmation that gonadotropins have no direct/obvious effects on the early stages of 
follicle development. Meanwhile, several reports confirmed that BMP-4 is a key player in 
regulating follicle development; our observation dose not contradict the fact the BMP-4 is 
essential for follicle development as reported by skinner (Nilsson and Skinner, 2003) but  
rather suggests that BMP-4 may be involved in activation of other mechanisms, possibly by 
affecting apoptosis and/or enhancing  primordial germ cell formation from mesenchymal 
stem cells (Zhou et al., 2011). However,  this possible explanation requires further study. 
There may be a role for interaction with epidermal growth factor (EGF). An in vitro study 
demonstrated that pre-antral follicle development and steroidogenic activity in mice can be 
modulated by the action of EGF (Almahbobi et al., 1995). In addition, it has been reported 
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that  EGF appeared to down regulate the FSHR expression in mice (Findlay and Drummond, 
1999) and a separate study showed that BMP-4 has inhibitory effects on EGF production in 
mice (Chen et al., 2013). Therefore, it may be possible that the attenuation of BMP-4 causes 
the up regulation of EGF which could abolish the eCG effect on gonadotropin receptor 
expression.   
Finally, the interaction between the BMPs and gonadotropins was investigated at the nuclear 
level. The relative expression at transcript levels for BMPR-1B, FSH and LH receptors were 
studied in mice immunised against BMPR-1B or BMP-4 with and without eCG administration. 
Although whole ovaries were used in the experiment, the expression of FSHR and LHR were 
restricted to granulosa and theca cells.  
In addition to the protein level interaction between the BMPR-1B and gonadotropin receptors  
in the previous study, which was visualized by in situ immune-localisation, this particular study 
revealed increase in FSHR and LHR transcript levels specific to ovaries immunised against 
BMPR-1B. The elevation of transcript levels of FSHR and LHR was observed in case of ovaries 
administrated with eCG indicating the involvement of gonadotropin in overall follicle 
development. However, the previous studies confirm non-dependence of gonadotropin on 




Chapter 8 : Conclusion 
Based on the data generated in this thesis, we consider that the current study is significant 
for several reasons. Firstly, the current study highlights the necessity and feasibility of using 
computerised 3D image analysis to detect and quantify the presence and distribution of a 
small quantity of molecules in a complex structure such as the ovarian follicles.    
Secondly, this study demonstrates that the role BMP signalling system is likely to be an 
important regulator of ovarian function, in particular the process of follicle development, 
depletion and ovulation. Furthermore, the attenuation of BMP signalling system is an 
effective approach to increase female fertility reserve while promoting follicle development, 
ovulation and eventually the overall fertility. Furthermore, this study also demonstrated 
unequivocally the interaction between BMPs signalling and gonadotropin regulates the 
follicle development and provides a further confirmation that the process is tightly controlled 
by the BMPs action, directly by regulation the early stages for follicle development and 
indirectly by enhancing the follicle cells sensitivity towards gonadotropin hormones which 
ultimately leads to enhances the reproductive capacity. 
The outcomes of the current study enhance our understanding of the mechanisms involved 
in the interplay between BMPs signalling and gonadotropin, hence the regulation of the rate 
of primordial follicle recruitment and depletion. This will have a great potential application in 
controlling the onset of menopause, hence increasing female fertility. Additional research and 
investigations are required to further determine the role of FSH and LH in ovarian BMPR 
expression with respect to specific BMP ligands. The findings of this study gives additional 
insights for the development of future preventative and/or therapeutic approaches to 
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The temporo-spacial expression of BMP, FSH and LH receptors during early 
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In mammals the ovary contains a finite number of primordial follicles, which serve as a 
fertility reserve for the whole reproductive age. Continuous and high rate usage of these 
follicles will results in complete depletion, cessation of ovarian function and infertility. We 
have reported that bone morphogenetic proteins (BMPs) are involved in the formation and 
development of ovarian follicles in human 1 and sheep 2. Specifically, it is commonly believed 
that the process of initial recruitment of primordial follicles to the pool of growing follicle is 
not gonadotropin- but BMP-dependent. However, this has not yet been unequivocally 
confirmed. The aim of this study is to elucidate the interplay between BMPs and 
gonadotropins, FSH and LH in early folliculogenesis by demonstrating the temporo-spacial 
protein expression of the BMP receptors (BMPR), FSHR and LHR in reserve primordial and 
growing follicles. Ovarian serial 10 µm cryosections were prepared for in situ 
immunofluorescence labelling of several follicular stages and subjected to microscopy 
examination and computer-based quantitative analysis. Cell membrane-bound FSHR, LHR 
and BMPR are found in granulosa cells of the follicles. While BMPR is expressed in all follicle 
stages, FSHR is absent in granulosa cells of primordial follicles and LHR is absent in granulosa 
cells of both primordial and primary follicles. Quantitative analysis based on the intensity of 
fluorescent signals shows that the expression of BMPR, FSHR and LHR significantly (p< 0.001 
p< 0.0001 p< 0.0001 respectively) increases with follicular development. We conclude that 
the initial recruitment of primordial follicles to primary stage is possibly BMP-dependent 
with no apparent direct input of gonadotropins. The interplay between BMPs and 
gonadotropins becomes eventually effective from primary follicles onward. The outcome is 
significant in understanding the role of BMP signalling pathway in the regulation of the rate 
of primordial follicle depletion. This will have a great potential application in controlling the 
onset of menopause hence increasing female fertility. 
1. R egan et al.2011, WC R B  
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Passive immunisation is a useful model to study the role of BMPs in the regulation 
of ovarian follicle development in mice (#240) 
S arme d Al-S ame rria 1 , Ibtisam I Al-Ali 2 , J im J  McF arlane 2 , G hanim Almahbobi 1 
1. C urtin Univers ity, Bentley, WA, Australia  
2. Physiology, Univers ity of New E ngland, Armidale, NS W, Australia  
Ovarian fertility reserve, present in form of primordial follicles, which represent the 
longevity and quality of reproductive activity. Complete depletion of fertility reserve with 
age due to high rate of consumption will lead to the cessation of ovarian function in 
mammals and specifically menopause in women. The initial transition from primordial to 
primary follicle is the key limiting step of follicle development and consumption. 
Folliculogenesis is primarily a gonadotropin-dependent process in addition to the role of 
several other factors such as the bone morphogenetic proteins (BMPs). However, the 
regulation of initial follicle development is generally known as gonadotropin-independent 
but other conflicting reports indicate otherwise and this discrepancy needs to be 
unequivocally clarified. Using a computerised stereological analysis, the aim of this study 
was to investigate the role of BMPs in the regulation of primordial follicle depletion and rate 
of primary follicle survival in different ages of pass ively immunised mice against BMP 
receptor 1B (BMPR1B) and BMP-4 with and without treatment with the gonadotropin 
PMSG. The mean total numbers of primordial follicles in immunised mice with anti-BMPR1B 
and anti-BMP-4 were significantly (p<0.0001) increased with ratios up to 205% to the 
numbers present in control animals of the same age. Treatment with PMSG alone has no 
effect on the numbers of primordial follicles. However, PMSG treatment of immunised mice 
abolished the increase in numbers of primordial follicles resulted from immunisation. The 
mean total numbers of primary follicles in immunised mice were also significantly 
(p<0.0001) increased with ratios up to 175% to those present in control animals of the same 
age. In contrast to the case of primordial follicles, treatment with PMSG alone or as a 
supplement with antibodies significantly reduced the number of primary follicles to a 
minimum ratio of 59% of follicles in control animals. The rates of primary follicle survival 
were decreased after puberty with age and particularly significant in treated animals. 
However, there was no significant difference in the survival rates of primary follicles 
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The effect of impaired function of BMPs by passive immunisation on the protein 
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The number and quality of ovarian follicles are important in determining the longevity and 
integrity of female fertility. It is well known that the survival and development of these 
follicles including ovulation, which results in the release of viable oocytes ready for 
fertilization, are controlled primarily by the gonadotropins. However, there is increasing 
evidence which suggests that there are several other factors such as the bone 
morphogenetic proteins (BMPs) which co-regulate ovarian function along with 
gonadotropins. In our recent studies in an attempt to shed light on the mechanism of action 
of BMPs, we have created an in vivo mouse model with attenuated BMP signalling using 
passive immunisation against BMPR1B and BMP-4. The aim of this study was to investigate 
the localisation of BMP receptor 1B (BMPR1B), FSHR and LHR in the ovaries of mice treated 
with anti-BMPR1B, and anti-BMP-4 with and without exogenous gonadotropins (eCG). 
BMPR1B was expressed in all follicle stages, FSHR was detected in primary follicles onward 
and LHR was absent in primary follicles but appeared in later stages. Quantitative analysis 
based on the intensity of fluorescent signals showed that the expression of BMPR1B, FSHR 
and LHR significantly increased in the granulosa cells of the pre-ovulatory and secondary 
follicles in mice treated with anti-BMPR1B. Mice treated with anti-BMP-4 show that the 
expression of BMPR1B and FSHR but not LHR increased significantly in pre-ovulatory follicles 
only with no effects observed in any other stages. The pre-ovulatory follicles in mice treated 
with eCG showed increased BMPR1B and FSHR but not LHR expression. These results 
together with our previous reports in sheep and mice confirm that the attenuation of BMP 
signalling system can be an effective approach to sustain the development of growing 
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Figure 9-1: Animal groups and treatments 
